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Introduction/Aim 
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Keratinocytes are the first port of entry for Chlamydia trachomatis of the 
lymphogranuloma venereum (LGV) biovar which causes LGV. However LGV 
pathogenesis and gene expression studies are usually performed in cells which are not 
the native host cells. In this study we investigated chlamydial gene expression in a 
keratinocyte cell line at both core (37C) and skin (33C) temperature in an attempt to 
understand what happens in vivo. 
Methods 
C. trachomatis infected HaCaT cells were incubated at either 33oC or 37oC. The level 
of expression of six genes which are known to be expressed at different times during 
the chlamydial lifecycle was quantified relative to a house keeping gene (16s rRNA). 
Transmission electron microscopy (TEM) was performed to confirm the stage of the 
developmental cycle that the organism was at inside the keratinocytes. The results of 
the gene expression assays were compared with TEM done under the same conditions. 
Results 
As expected, the early cycle genes groEL and incB were expressed throughout the life 
cycle at both temperatures for all the chlamydial strains tested.  At 37oC, L2 434 showed 
an over 30-fold increase in incB expression level at 2 hours post infection, compared to 
L2 US151 in which a constantly lower level of expression was observed. 
Pyk-F expression was most abundant at 2 hours post infection at 37oC in all tested 
chlamydial strains. Tal on the other hand was expressed the highest at 12 hours post 
infection for strain E, which correlates with rapid growth and division of RBs. This was 
consistent with the electron microscopic observations. At 33oC, both pyk-F and tal were 
most abundant from 24 hours post infection. This was also consistent with the TEM 
observations in which the metabolically active RB form was only observed from 24 
hours post infection at 33oC. At 37oC an increase in hctA expression was observed at 2 
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hours post infection and decreased by 1- fold at 12 hours post infection for L2 434 and 
serovar E. At 33oC; hctA expression was abundant from 24 hours post infection for L2 
434 and US151, although hctA was still expressed in low levels at 2 and 12 hours post 
infection. Strain E had two expression peaks of hctA, at 24 and 72 hours post infection. 
Like hctA, at 37oC strain L2 434 showed high omcB expression level at 2 hours post 
infection. At 12 hours post infection the expression level was suppressed, but 
upregulated again at 24 hours post infection. At 33oC, Both L2 reference strains and 
strain E only expressed omcB from 24 hours post infection and increased at 36 hours 
post infection. This was consistent with the TEM, which showed numerous EBs at 36 
hours post infection. 
 
Discussion/Conclusion 
This study confirms that mid and late-cycle chlamydial gene expression levels are 
different to the published research conducted in HeLa cells at 37oC.and that temperature 
has an effect on the level of chlamydial gene expression when grown in keratinocytes. 
At 2 hours post infection chlamydia still retains its EB structural conformation in 
keratinocytes at 37oC. The L2 reference strain 434 is different than the clinical L2 
US151as indicated by the difference in the gene expression pattern. 
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CHAPTER 1: INTRODUCTION 
 
Chlamydia trachomatis is an obligate intracellular gram-negative bacterium, which is 
associated with various sexually transmitted diseases. 
The species Chlamydia trachomatis is traditionally subdivided into two biovars: the 
lymphogranuloma venereum (LGV) and oculogenital (OG) biovar. This is based on the 
differences in disease manifestation (Ward 1983). The differences in clinical disease of 
the OG biovar as well as differences in the variable region of the chlamydia genome, 
known as the plasticity zone, indicate that C. trachomatis should be divided into three 
biovars: trachoma/oculo (O), genital (G) and LGV biovar (Carlson, Porcella et al. 
2005). Strains of the LGV biovar target the keratinocytes in the primary stage of 
infection whereas G biovar strains target cervical and urethral epithelial cells (Joubert 
2010). 
Chlamydia are characterized by a unique two-phase developmental cycle. In the 
extracellular phase, the organism manifests as the elementary body (EB). This EB is 
infectious and metabolically inactive. Once the EB is endocytosed it differentiates into 
the metabolically active reticulate body (RB) which replicates within inclusions by 
binary fission (Hanada, Ikeda-Dantsuji et al. 2003). The chlamydia revert back into the 
metabolically inactive EB that is released from the host cell to infect additional cells in 
the same or in the next host (Beagley and Timms 2000, Sherrid and Hybiske 2017). 
Chlamydia were previously thought to be viruses because of their obligate intracellular 
life cycle. Until recently, chlamydia were described as true energy parasites in that they 
require both energy (ATP) and nutrients from the host cell and that they are not capable 
of de novo nucleotide synthesis and must rely on host nucleotides for replication (Black 
1997). 
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Keratinocytes are the first port of entry for Chlamydia trachomatis of the LGV biovar, 
which causes lymphogranuloma venereum (LGV). LGV is an invasive, sexually 
transmitted disease of humans, which begins as an ulcer in the genital region.  The 
chlamydia of the LGV biovar infect viable keratinocytes in the stratum spinosum and 
basale of the epidermis. The ulcers that appear vary in size and tend to heal 
spontaneously. From these skin lesions, the bacteria migrate to the inguinal lymph 
nodes causing lymphadenopathy. LGV pathogenesis and gene expression studies are 
usually performed in cells other than keratinocytes that are not the native host cells.  
Furthermore, the initial site of infection, the skin, and the secondary site of infection, 
the inguinal lymph nodes have different temperatures.  The temperature of human skin 
(port of entry) is 33C, while the temperature of the inguinal lymph nodes is 37C.  
Most previous studies have only focused on the latter temperature.  Joubert and Sturm 
(2011) have demonstrated that C. trachomatis does infect keratinocytes in vitro both at 
37C and 33C, although they replicate faster at 37C than at 33C.  This study aims to 
determine the relative level of expression of two early, two mid-cycle and two late-
cycle chlamydial genes (Shaw, Dooley et al. 2000) when grown in keratinocytes, to 
compare the differences in the expression of these genes at 37o versus 33°C and to 
compare the gene expression results to the level of morphological differentiation by 
means of electron microscopy.  
 
To date there have been no gene expression studies of chlamydia in keratinocytes, 
which is the first target of infection for organisms of the LGV biovar, and no studies 
have compared gene expression at core (37°C) versus surface temperature (33°C) of 
the human host.  
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CHAPTER 2: LITERATURE REVIEW 
 
2.1 Classification of Chlamydia trachomatis 
 
Chlamydia constitute one of the most successful groups of obligate intracellular 
bacteria. Over the past 10 years, the taxonomy and nomenclature of the chlamydia have 
changed. Originally, Chlamydia trachomatis and Chlamydia psittaci were the only two 
species that were under the order Chlamydiales, family Chlamydiaceae and genus 
Chlamydia. The genus Chlamydia is characterized by its unique developmental cycle 
(Debattista, Timms et al. 2003) and the two species were distinguished based on their 
characteristics such as sensitivity to sulfodiazine, host range and the buildup of 
glycogen within the chlamydial inclusions. Two other species were later recognised, 
Chlamydia pneumoniae in 1989 and Chlamydia perocum in 1992. Both these species 
were subgroupings within C. psittaci (Black 1997). 
 
For many years C. trachomatis was subdivided into two biovars: the oculogenital or 
OG biovar and the lymphogranuloma venereum orLGV biovar. Currently genotyping, 
based on the gene encoding MOMP, is more commonly with ompA genotypes A–C 
associated with trachoma, D–K with urogenital infections, and L1–L3 with LGV. 
Recent publications have confirmed previous findings that ompA is not a reliable 
marker of phylogeny due to extensive recombination within the genomes of C. 
trachomatis strains (Seth-Smith, Harris et al. 2013) 
 
 
Over the past 5 years, the use of molecular methods has led to the discovery of more 
phylogenic groupings within the Chlamydiaceae family. Based on sequence analysis of 
the 16SrRNA and 23SrRNA genes it has been proposed to divide the Chlamydiaceae 
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family into two genera: Chlamydia and Chlamydophila. Together, these two genera 
harbour nine species (Table 2.1) (Everett, Bush et al. 1999, Beagley and Timms 2000). 
Table 2.1: Chlamydiaeceae genera and species 
Genus  Species  Host infected  Diseases caused 
Chlamydia C. trachomatis Humans sexually 
transmitted 
diseases, trachoma, 
neonatal 
conjunctivitis 
 C. muridarum mice, hamsters respiratory 
infections, 
pneumonia, ileitis 
 C. suis Swine conjunctivitis, 
enteritis, 
pneumonia 
 C. abortus cattle, sheep, goats abortion 
 C. psittaci humans, birds pscittacosis, 
systemic disease 
 C. caviae guinaea pigs genital tract 
infections, 
conjunctivitis 
 C. felis Cats conjunctivitis, 
rhinitis 
 C. percorum cattle, sheep, 
goats, koalas, 
swine 
reproductive 
disease, 
conjunctivitis, 
abortion, 
pneumonia, 
encephalomyelitis, 
enteritis 
 C. pneumoniae humans, horses, 
koalas 
pneumonia, other 
respiratory tract 
infections 
 
 
2.2 Disease manifestations associated with chlamydia 
 
 Among the strains of C. trachomatis, there are 15 serovars based on the differences in 
the epitopes found on the major outer membrane protein (MOMP): 3 lymphogranuloma 
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venereum (L1 to L3) and 13 oculogenital serovars (A, B, Ba, C, D, Da, E, F, G, H, I, J 
and K) (Ward 1983). 
Of the sexually transmitted chlamydia, the genital biovar consisting of serovars D-K is 
most common. It causes urethritis, epididymitis and prostatitis in male and cervicitis, 
urethritis and pelvic inflammatory disease in female. The genital biovar is also found 
as a cause of conjunctivitis in neonates born from chlamydia infected mothers 
(SHERMAN, DALING et al. 1990, Fredlund, Falk et al. 2004)   
 The LGV strains are different from other strains of C. trachomatis in that they are more 
invasive, resulting in initial infection of the epithelial layers followed by spread in the 
lymphatic tissue (Söderlund and Kihlström 1982) (Bébéar and De Barbeyrac 2009). 
The classic presentation of LGV consist of three stages. The primary stage is a painless 
genital ulcer that evolves into the secondary stage, which is inguinal lymphadenopathy. 
This is followed by genito-anorectal syndrome, which is the tertiary stage (Schachter 
and Osoba 1983). Not all stages are seen in each patient. 
 
2.3 Pathogenesis of chlamydial infection 
 
C. trachomatis exercises its pathogenicity during its interaction with the host cell and 
when it is released from the infected cell to infect further uninfected host cells. Like 
most intracellular organisms, chlamydia escape defence mechanisms of the host by its 
intracellular lifestyle in which the cell provides a protective environment (Beatty, 
Morrison et al. 1994, Belland, Zhong et al. 2003, Frohlich, Hua et al. 2014). 
 
The infectious chlamydial form, the elementary body (EB), adheres to the host cell 
membrane and initiates entry. The membrane of the EB contains proteoglycan, a ligand 
through which the EB attaches to microvilli of the host cell and is subsequently 
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embedded in clathrin-coated vesicles. Within the host cell, the EB remains within the 
non-acidic intracellular vacuole, avoiding fusion of the phagocytic vesicle with the host 
cell lysosome, thus allowing it to escape the endocytic pathway and establishing 
fusogenicity sphingomyelin-containing exocytic vesicles, called inclusion bodies 
(Hackstadt, Scidmore et al. 1995, Shaw, Dooley et al. 2000, Wyrick 2010). These 
chlamydia containing inclusion bodies are then redistributed from the cell periphery to 
the area around the nucleus.  
Under stressful conditions in vitro, C. trachomatis can enter into an alternative viable 
but non-dividing growth form, known as the persistent growth form (Beatty, Morrison 
et al. 1994, Frohlich, Hua et al. 2014). Persistent growth of chlamydia may correlate to 
a reduction in metabolic activity, which restricts growth and division and delays 
differentiation to mature EBs. Limited metabolic capacity may also influence the 
biochemical and antigenic attributes of the persisting organisms, potentially rendering 
them undetectable by normal diagnostic tests (Beatty, Morrison et al. 1994).  This 
persistent growth state has been suggested to be linked to chronic infection and 
unfavourable outcomes, including stimulation of tissue damaging host responses 
(Darville and Hiltke 2010). Persistent forms are also less responsive to antimicrobial 
therapy in vitro and in vivo (Phillips-Campbell, Kintner et al. 2014). 
 
2.4 Morphology 
 
Chlamydia display a life cycle that involves the consecutive alternation of two distinct 
morphological forms, the elementary body (EB) and the reticulate body (RB). 
 
2.4.1 Architecture of cell envelope 
 
One of the important developmental events shared by chlamydia species is the ability 
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of the organisms to adapt their envelopes for the purpose of interacting with the host 
cell. Like other Gram-negative bacteria, the C. trachomatis envelope consists of an 
outer membrane (OM), an inner membrane (IM), and a periplasm (Frohlich, Hua et al. 
2014). Recent studies by (Pilhofer, Aistleitner et al. 2013, Liechti, Kuru et al. 2014) 
have shown that chlamydia have a functional peptidoglycan (PG). The existence of PG 
has long been debated. Whereas genetic analysis and susceptibility to antibiotics 
indicate the presence of PG, yet all attempts to detect PG have proven unsuccessful, 
resulting in the ‘chlamydial anomaly’ (Moulder, Novosel et al. 1963, Tamura and 
Manire 1968, Stephens, Kalman et al. 1998). Liecthi, et al (2014) have recently 
demonstrated the presence of PG in C. trachomatis by a new metabolic cell wall 
labelling method and observed that chlamydial PG is present in a ring-like structure at 
the apparent cell division plane and does not appear as a sacculus form.  
 
The chlamydial envelope possesses a cross-linked outer membrane protein (MOMP), 
which is a unique feature that distinguishes chlamydia from other Gram-negative 
bacteria. The most exposed surface molecule of both EBs and RBs is the MOMP and 
this functions as an adhesin and as a porin (Caldwell, Kromhout et al. 1981, Wang, 
Berg et al. 2006). MOMP is also capable of adapting to different chlamydial stages by 
altering its conformation (Feher, Randall et al. 2013). MOMP contains cysteine rich 
omcB and omcA. These cross-linked cysteine rich proteins contribute in osmotic 
stability and cell rigidity of the EBs (Frohlich, Hua et al. 2014).  
 
2.4.2 Elementary body 
 
The elementary body (EB) is the extracellular, infectious and metabolically inactive 
form of the chlamydia which is responsible for attaching to the target host cell (Ward 
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1983, Beatty, Morrison et al. 1994). EBs are 0.2 – 0.3 m in diameter and are rigid, 
allowing them to be osmotically stable, to endure environmental stress and to survive 
after lysis of the host cell (Ward 1983). EBs have highly condensed DNA in an electron-
dense nucleoid which is detectable by transmission electron microscopy (Siegl, Horn 
et al. 2012).  EBs have highly cross-linked disulfide bonds on the MOMP formed by 
two cysteine rich proteins. These are a 60 kDa envelope protein and 12 kDa outer 
membrane lipoprotein, which enhance structural stability and enables the EB to attach 
to and enter host cells (Sardinia, Segal et al. 1988). The role of EBs is to allow spread 
of chlamydial infection from one cell to another (Beatty, Morrison et al. 1994).  
 
2.4.3 Reticulate body 
 
The reticulate body (RB) is the intracellular, non- infectious and replicative form of 
chlamydia which cannot survive outside the host cell (Beatty, Morrison et al. 1994). 
RBs are larger in diameter than EBs (1m). Their cell wall is fragile and osmotically 
sensitive, probably because of the absence of cross-linked disulfide bonds on the 
MOMP. The MOMP forms pores that provide a passageway for nucleotides, 
metabolites and ATP from the host cell to the chlamydial cell. Protein synthesis in RBs 
depends on the ATP-ADP exchange mechanism not possessed by EBs (Moulder 1991). 
They also have dispersed DNA; allowing activation of DNA signals, chlamydial protein 
synthesis and RB replication. RBs contain endosome intercepts for expansion of the 
membrane bound vesicle called an “inclusion” to accommodate the increasing number 
of replicating RBs (Wyrick 2010). 
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2.5 The life cycle of chlamydia 
 
Chlamydia are characterized by a unique two-phase developmental cycle comprising 
two cell types; EBs and RBs. EBs are incapable of dividing. They are released from 
infected cells to infect adjacent host cells, where they transform into RBs. RBs are 
incapable of infecting new host cells, they replicate and eventually rearrange into a new 
population of EBs. The entire cycle takes place within a vacuole termed an inclusion 
(Shaw, Dooley et al. 2000).  
 
Infection is induced following the attachment of an EB to the host cell.  The 
internalization of LGV strains into a target cell is not dependent on the cytoskeleton, 
whereas internalization of OG strains is enabled by microvilli (Schramm and Wyrick 
1995, Wyrick 2010). EB remain in an inclusion, which does not fuse with the host cell 
lysosome (Hammerschlag 2002). Within the first 2 to 6 h post infection, differentiation 
of EB into RB begins. During this transition the organism loses its infectivity, increases 
in size, its chromosome is decondensed and there is an increase in metabolic activity 
(Moulder 1991, Belland, Zhong et al. 2003). RBs replicate within inclusions by binary 
fission, forming a microcolony. As this microcolony grows, the inclusion membrane 
expands to accommodate the differentiating RBs.  After 18 to 24 h post infection the 
numbers of RBs have increased and they start to revert back to the EB form, which 
accumulate in the lumen of the inclusion as the remaining RBs continue multiplying 
(Shaw, Dooley et al. 2000, Nicholson, Olinger et al. 2003). Depletion of nutrients and 
ATP during replication of RBs serve as a signal for RBs to mature and reorganize back 
to infectious EB (Wyrick 2010). Approximately 48 h post infection the cell lyses and 
releases mature EBs to infect more host cells (Belland, Zhong et al. 2003). With the 
OG strains, release is through exocytosis while LGV strains are released through cell 
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cytolysis (Todd and Caldwell 1985). Extrusion of the entire inclusion may occur, 
resulting in a silent, chronic infection (Hammerschlag 2002). 
2.5.1 Attachment and ingestion 
 
The surfaces of EBs are hydrophobic and negatively charged at a neutral pH. Host cells 
are also negatively charged at pH 7. The negatives charges on the surfaces of both 
chlamydia and the host cell mainly represent free carboxyl groups. With both 
interacting surfaces carrying a net negative charge, the question arises as to how 
chlamydia ever attach to the host cells. It has been suggested that the neutralization of 
the chlamydial ligands by electrostatic interaction with the host cell ligands results in 
the binding of chlamydia to the host cell by Van der Waals forces (Moulder 1991).  
Entry of the EB is promoted by actin cytoskeleton in the cell wall (Carabeo, Grieshaber 
et al. 2002). As soon as an inclusion is formed, entry of additional EBs into that host 
cell is blocked (Moulder 1991).  
 
2.5.2 Metabolic capacity 
 
Previously it was believed that chlamydia lack the enzymes required for ATP synthesis, 
therefore making the intracellular developmental cycle dependent on ATP obtained 
from the host cell and possibly on a number of other host-acquired high-energy 
metabolites.  
 
However, recent findings suggest that chlamydia may not live as energy parasites 
throughout the developmental cycle and that elementary bodies are not metabolically 
inert but exhibit metabolic activity under appropriate axenic conditions (Omsland, 
Sager et al. 2012, Omsland, Sixt et al. 2014). 
 
11 
  
Chlamydia contain genes that code for the enzymes for conversion of glucose-6-
phosphate to pyruvate via glycolysis. This allows them to generate ATP via substrate 
level phosphorylation by the enzymes phosphoglycerate kinase and pyruvate kinase. 
To determine whether chlamydia contains functional enzymes involved in a glycolysis 
or pentose phosphate pathway (PPP), four enzymes involved in glycolysis and PPP 
were cloned, sequenced and expressed as recombinant proteins in E. coli. The deduced 
amino acid sequences showed high homology to other enzymes of glycolysis and PPP 
(Iliffe‐ Lee and McClarty 1999). 
 
The TCA cycle is known to be incomplete in the Chlamydiaceae family due to the 
absence of the enzymes citrate synthase (GltA), aconitase (Acn), and isocitrate 
dehydrogenase (Icd) (Carlson, Porcella et al. 2005). Therefore, a constant metabolite 
exchange with the host cell is required to initiate the TCA cycle (Stephens, Kalman et 
al. 1998). 
 
2.6 Gene expression 
 
Previous gene expression studies have only been performed in either HeLa or Hep-2 
cell lines at 37oC and have shown that a number of chlamydial genes are temporally 
expressed during the developmental cycle. The mechanism of regulation is largely 
unknown. Analysis performed by Shaw et al., (2000) and Belland et al., 2003 suggested 
that C. trachomatis transcription occurs in three temporal phases: early (2 h post 
infection), mid- cycle (6- 18 h post infection), and late (24- 48 h post infection). Gene 
products are only transcribed temporarily when they are required in the developmental 
cycle (Niehus, Cheng et al. 2008). Transcription begins instantly after internalization. 
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De novo transcription and translation are required to facilitate and coordinate molecular 
events occurring during the developmental cycle (Abdelrahman and Belland 2005).  
 
2.6.1 Early gene expression 
 
As the chlamydial developmental cycle begins, the formation and modification of the 
unique intracellular niche, called an inclusion, also occurs. The inclusions are non-
fusogenic with host lysosomes. The inclusion membrane is significantly modified by a 
set of chlamydial proteins collectively known as Incs which are assumed to be 
significant in chlamydial pathogenesis (Fields, Fischer et al. 2002). It is hypothesized 
that Inc proteins are involved in the trafficking and fusion of chlamydial inclusions 
(Shaw, Dooley et al. 2000). When the inclusions are trafficked along microtubules they 
associate with the host-derived lipids to sustain integrity as they increase in size during 
RB replication 
 
The Inc proteins belong to a class of proteins expressed early in the chlamydial 
developmental cycle. Among the early events of chlamydial infection is extensive 
modification of the inclusion membrane by the insertion of a number of type III secreted 
effector proteins (Mital, Miller et al. 2013). Studies have shown the presence of several 
Incs located in the inclusion membrane. These Inc proteins lack primary sequence 
homology; however, they are all characterized by the absence of an N-terminal and the 
presence of bi-lobed hydrophobic domains comprising 40 to 60 amino acid residues 
(Pannekoek, van der Ende et al. 2001, Fields, Fischer et al. 2002).  
 
The chlamydial heat shock protein GroEL is another example of protein expressed early 
in the chlamydial developmental cycle (Karunakaran, Noguchi et al. 2003) and 
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represent macromolecular biosynthetic and protein processing pathways because they 
produce the  subunit of DNA polymerase (Shaw, Dooley et al. 2000). GroEL 
expression increases during a variety of conditions such as heat shock, nutrient 
deprivation, infection, and inflammatory reaction and functions to stabilize cellular 
proteins (Young and Elliott 1989). GroEL proteins are highly conserved in sequence 
among bacteria and are recognized in the host by Toll-like receptors as part of an innate 
defense system (Karunakaran, Noguchi et al. 2003).  
 
2.6.2 Mid-cycle gene expression 
 
During the mid-cycle the transition of infectious EB into non-infectious, metabolically 
active RB occurs. RB replicate within an inclusion by binary fission until late in the 
infection (Shaw, Dooley et al. 2000). 
Genes expressed in the mid-cycle are associated with energy metabolism. An example 
of mid-cycle genes is pyruvate kinase (pyk), an enzyme of glycolysis which catalyzes 
the irreversible conversion of phosphoenolpyruvate to pyruvate with the release of ATP 
(Mathews, George et al. 2001).  This reaction is a main regulatory point in the 
glycolysis pathway which controls the flux of the glycolytic intermediates and regulates 
the level of ATP in the cell (Fothergill-Gilmore and Michels 1993). Pyk enzymes can 
be classified as type I pyk and type II pyk. Type I pyk is dominant during glycolysis, 
where it is activated by fructose -1, 6- bisphosphate (F16BP). Type II pyk is dominant 
during gluconeogenesis, where it is activated by AMP, ribose -5-phosphate (R5P) and 
glucose -6-phosphate (G6P) (Iliffe‐ Lee and McClarty 2002). 
Chlamydia trachomatis pyruvate kinase (CTPK) is an allosteric enzyme that is 53.5 
kDa with a pH of 7.3 and requires monovalent (K+) and divalent (Mg2+) for its activity. 
CTPK has been discovered to be the only known bacterial Pyk that is allosterically 
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activated by fructose -2, 6- bisphosphate (F26BP) (Fothergill-Gillmore, Rigden et al. 
2000). Chlamydia do not have enzymes to metabolize F26BP. However, according to 
the information from the chlamydial genomic sequence, chlamydia do contain a small 
number of genes for the biosynthesis of metabolites and the genes for transporters with 
extensive substrate specificity. This suggests that chlamydia have transport systems for 
obtaining metabolites from the host. Therefore, chlamydia may acquire F26BP from 
the host. Sugar monophosphates such as G6P, F6P, R5P can also activate CTPK, thus 
suggesting that CTPK has properties for both type I and type II Pyk (Iliffe‐ Lee and 
McClarty 2002). 
 
Gene encoding transaldolase (tal) of the pentose phosphate pathway (PPP) is also 
detected in the mid-cycle (Shaw, Dooley et al. 2000). This enzyme is important for the 
balance of metabolites in the PPP by increasing the catabolism of sugars. Transaldolase 
is involved in step 2 of the sub pathway that synthesizes D-glyceraldehyde 3-phosphate 
and beta-D-fructose 6-phosphate from D-ribose 5-phosphate. This sub pathway is part 
of PPP, which is itself part of carbohydrate degradation. 
 
2.6.3 Late gene expression  
 
Late in the chlamydial developmental cycle the non-infectious RB reorganize back into 
infectious EB. During this process genes encoding structural and regulatory proteins 
are expressed (Shaw, Dooley et al. 2000). 
 
hctA is an example of the genes expressed late in the chlamydial developmental cycle 
and it is defined as a lysine rich protein with a primary sequence similar to the 
eukaryotic histone Hc1(Niehus, Cheng et al. 2008). This histone-like protein is 
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produced late in chlamydial developmental cycle during the conversion of RB to 
infectious EB and it mediates the condensation of the chromosome. As RB replication 
begins during the first few hours of infection, the condensed chromosome of EB is 
decondensed. The histone-like protein binds to and blocks the hctA gene to repress its 
transcription and translation. IhtA, a small non-coding RNA, regulates expression of 
this protein. In the early stages of the developmental cycle IhtA gene is transcribed and 
its product, the IhtA regulatory RNA, represses the translation of this IhtA protein, 
ensuring that it remains low and constant until RB start reorganizing to EB. 
Transcription of IhtA decreases late in the developmental cycle, allowing synthesis of 
hctA (Tattersall, Rao et al. 2012).  
 
The outer membrane complex protein B (omcB) is the most abundant and conserved 
outer membrane protein in chlamydia (Hou, Lei et al. 2013). OmcB functions as an 
adhesin during attachment of EB to the host cell and also contributes to osmotic stability 
and cell rigidity involved in the final stage of the life cycle (Shaw, Dooley et al. 2000). 
Therefore, omcB is expressed late in the chlamydia developmental cycle. 
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CHAPTER 3: MATERIALS AND METHODS 
 
3.1 Cell culture 
 
3.1.1 Cell line 
 
The HaCaT cell line was used for both propagation of chlamydia and the experimental 
work.  It is a spontaneously immortalized human keratinocyte cell line (Boukamp et al. 
1988) donated in 1995 by Professor N. E. Fusenig of the Cancer Research Centre, 
Heidelburg, Germany. 
 
HaCaT cells were cultured in Roswell Park Memorial Institute 1640 (RPMI 1640) 
medium (Lonza) with HEPES (10 mM), L-glutamine (2 mM) and 10 % foetal bovine 
serum (FBS) (Biowest). Unless stated otherwise, for all experiments FBS was heat 
inactivated for 30 minutes at 56oC 
 
3.1.2. Retrieval of frozen cells and maintenance 
 
The cells were stored in cryovials at -80°C until required. When required the cell 
suspensions were thawed in a 37°C water bath under gentle agitation of the vial. After 
the cells were thawed, the cryovials were swabbed with 70% alcohol and transferred to 
a class II biological safety cabinet. The cell suspension was transferred into a 75 cm2 
cell culture flask containing RPMI 1640 supplemented with 10% FBS. The flasks were 
then incubated at 37°C. The colour of the media was checked and the cells were 
examined daily using an Olympus IX70-S8F2 inverted phase contrast microscope, in 
order to monitor the morphology, the density of cell growth and possible signs of 
contamination. Every 2-3 days the spent media was discarded and the cells were washed 
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once using phosphate buffered saline, pH 7.2 (PBS) (Oxoid) to wash off unattached 
cells. Fresh media were added and the monolayers reincubated if necessary. 
 
3.1.3 Trypsinisation and passage 
 
When the monolayers in the tissue culture flasks were approximately 90% confluent, 
the spent cell culture media (CCM) was siphoned off and the cells were washed three 
times with PBS to ensure that the FBS from the spent media and all unattached cells 
were removed. Two millilitres of 0.05 % ethylene-diamine-tetra-acetic acid (EDTA) 
(Sigma, Steinheim, Germany) were added to the culture flask to completely cover the 
monolayer.  Cells were then incubated at 37°C for 5-10 minutes. EDTA is a calcium 
chelator which saturates the remaining divalent cations (Mayer, Woods et al. 1993). 
Progress was checked by examination with the inverted phase contrast microscope. 
After incubation the cells appeared slightly rounded with small spaces between the 
cells.  The EDTA solution was then removed and discarded. One millilitre of 0.05 % 
trypsin - 0.02 % EDTA solution in distilled water (Whitehead Scientific - 
BioWhittakerTM) was added to the monolayer to detach the cells. Excess trypsin 
solution was discarded and the flask returned to the 37°C incubator to activate the 
trypsin.  Once the cells had become visibly rounded in appearance, the side of the flask 
was gently tapped against the hand to assist detachment of the cells. If trypsin is allowed 
to stay in contact with the cells for too long, the ability of the cells to attach to a new 
surface is reduced (Joubert 2010). One millilitre of FBS was then added to the flask to 
deactivate the trypsin. This cell suspension was seeded in new culture vessels for 
propagation, seeded in multi-well plates for experimental work or cryopreserved for 
later use. 
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3.1.4 Cryopreservation of cells 
 
After trypsinization an equal volume of cryopreservation fluid was slowly added to the 
cell suspension. Cryopreservation fluid for HaCaT cells contains 60% RPMI 1640, 20% 
glycerol (BDH Laboratory Suppliers) and 20% FBS. The mixture of cell suspension 
and cryopreservation fluid was then aliquoted into cryovials, labelled with the name of 
the cell type, passage number and date. Cells were allowed to freeze slowly overnight 
in an enclosed polystyrene rack at -80°C. The following morning the vials were 
transferred to a storage box and kept at -80°C. 
 
3.1.5 Determination of cell numbers 
 
The Neubauer haemocytometer was used to perform the Trypan Blue Exclusion assay. 
This was used to determine the total number of cells and viable cell numbers. Twenty 
microliters of cell suspension prepared as described in section 3.1.3 was added to 20 µl 
of 0.4 % trypan blue solution (Sigma, Steinheim, Germany). A cover slip was placed 
over the haemocytometer and a small amount of the trypan blue-cell suspension was 
transferred to each chamber of the haemocytometer by touching the edge of the cover 
slip with the pipette tip and allowing the chamber to fill by capillary action. The 
contents of the haemocytometer was then viewed under a bright field microscope 
(Nikon P60) at 40x magnification and the cells were enumerated. Viable cells appeared 
colourless because they can actively pump out the dye. The non-viable cells retained 
the blue colour because they are unable to pump out the dye (Pauwels et al., 1988). The 
number of cells per ml and percentage viability was calculated as follows: 
Concentration (cells/ml) = average cell count per primary square X dilution factor X10⁴ 
Total cell number = concentration x total volume 
% cell viability =
total viable cells (unstained)
total cells
× 100 
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3.2 Chlamydia trachomatis culture 
 
Three isolates were used for the experiments: the L2 reference strain 434 (ATCC® VR-
902BTM), one serovar L2 clinical isolate (US151) and one serovar E clinical isolate. 
US151 was grown by Joubert, 2009 from the ulcer specimen of a male patient at the 
Prince Cyril Zulu Communicable Diseases Clinic in Durban, South Africa for use in 
this pathogenesis study while strain E was isolated by Maleka and coworkers in 1996 
in our laboratory from a male patient presenting at the same clinic with urethritis. 
 
HaCaT cells were cultured in tissue culture flasks and passaged as described in 3.1.2 
and 3.1.3. One day before infection chlamydia growth media medium (CGM) was 
prepared. The medium consisted of the following: RPMI-1640 supplemented with 
glucose (5.4 mg/ml), 10 % FBS, 10 mM HEPES, 2mM L-glutamine, gentamicin (10 
µg / ml) and amphotericin-B (5 µg / ml).  
Once the cells reached 80% confluency, old media were removed, the monolayers were 
washed with PBS and CGM was added to each flask. Chlamydia EB suspension in 
sucrose-phosphate-glutamate (SPG) was added to each flask, excluding the negative 
control to which only SPG was added. Immediately after the inocula had been added 
the flasks were centrifuged for 1 hour at 1200 x g at 37oC and incubated for 1 hour at 
37°C in 5% CO2. The media was decanted and replaced with fresh media. The cultures 
were incubated for a further 2 days at 37°C in 5% CO2.  
After this incubation step, chlamydial inclusions were observed using an inverted phase 
contrast microscope. For harvesting of chlamydia, the medium was discarded and SPG 
supplemented with 10% FBS was added to each flask. After addition of 8 to 10 sterile 
glass beads the flasks were vortexed. The EB-SPG suspension so obtained was 
transferred to a centrifuge tube which was then centrifuged at 200 x g at 4°C for 10 
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minutes to pellet cell debris. The supernatant containing chlamydial particles was 
transferred to a fresh tube and aliquoted into cryovials which were labelled with the 
isolate number and date and stored at -80 °C.  
 
3.3 Quantification of chlamydia 
 
EB suspensions of each strain were thawed and seven 10-fold serial dilutions were 
prepared in SPG. These were used to infect 80% confluent HaCaT cell monolayers in 
a 96-well plate using the infection procedure described in 3.2. After 48 hours 
incubation, the monolayers were stained as described in paragraph 3.4 and viewed with 
a fluorescent microscope at 100 x magnification to detect chlamydial inclusion bodies 
(Joubert 2010). The number of chlamydial inclusions per field of view was counted. 
The chlamydial infectivity was determined using the following formula: 
IFU / ml = 
𝑖𝑛𝑐𝑙𝑢𝑠𝑖𝑜𝑛𝑠
𝑛
 x 
1000µ𝑙
𝑣
 x C x D 
Where: IFU = Inclusion Forming Unit 
n = number of fields counted 
            V = volume of inoculum (µl) 
            C = objective lens conversion factor 
            D = dilution (ml) 
 
3.4 Immunofluorescence staining and microscopy 
 
Cultures were stained using the MicroTrak® C. trachomatis Culture Confirmation Test 
Kit (Trinity Biotech).  This staining kit contains anti-C. trachomatis monoclonal 
antibodies raised against the major outer membrane protein (MOMP) present in all 15 
known human serovars of C. trachomatis and in both EBs and RBs. These monoclonal 
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antibodies are labelled with fluorescein isothiocynate (FITC) to facilitate species-
specific identification of the organism when present in a monolayer of cultured cells, 
causing chlamydial inclusions to fluoresce apple green in contrast to the host cells 
which are stained red due to the Evan’s blue counter stain. 
 
Immuno-fluorescence staining was performed as follows. Media were carefully 
aspirated from each well of the 96-well plate. The cell monolayers were immediately 
covered with 95% ethanol for 5 minutes to fix. Ethanol was aspirated and the 
monolayers were washed with PBS to remove remaining ethanol. 
 
Following fixation, 15 µl of the stain solution was added to cover the entire monolayer. 
The plate was covered with a damp gauze pad to create a humidified environment and 
prevent evaporation during incubation. The plate was incubated for 30 minutes at 37oC, 
5% CO2 and was agitated every 10 minutes to assure even distribution of the reagent 
during incubation. Excess reagent was aspirated and the stained monolayers were 
washed with distilled water. Excess water was removed by gentle tipping the inverted 
plate on a paper towel covered surface.  Plates were then turned back in the upright 
position and left to air-dry. 
 
The plate was viewed upside down (otherwise the objective could not get close enough) 
using a fluorescent microscope (Leica DM300) at an excitation/emission peak of 
495/517 nm. Chlamydial inclusions appeared apple green in contrast to the host cells, 
which were stained red. 
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3.5 Gene expression studies 
 
3.5.1 Study design 
 
The cells that were to be incubated at 37oC and 33oC for 2 or 12 hours were infected at 
an MOI of 100 while the cells that were to be incubated at 37oC and 33oC for longer 
periods were infected at an MOI of 10. We used the lowest MOI which allowed the 16S 
rRNA real-time PCR to produce a positive result.  A low MOI is thought to be more in 
keeping with the in vivo situation however we needed to increase the MOI to 100 for 
the earlier time points before the organism had begun to replicate. Expression of six 
chlamydial genes was quantified using real-time PCR and 16S rRNA was used as the 
reference gene. 
 
3.5.2. Cell culture and infection with C. trachomatis 
 
HaCaT cells were seeded into five 12-well plates (2 x 106 cells per well) and incubated 
at 37°C until the monolayer was approximately 80% confluent. Two of the 12 wells 
were trypsinized and cell counts were performed (see 3.1.3 and 3.1.5) to calculate the 
chlamydial inoculum to produce the required MOI. The cell culture media (CCM) was 
aspirated, the monolayers were washed with PBS to remove unattached dead cells and 
1 ml of chlamydia growth medium (CGM) was added to each well. The cells were 
infected with 100 µl of chlamydial suspension with the required concentration. For the 
negative control, 100 µl of sterile SPG buffer was added to the relevant wells. The cells 
were centrifuged at 1200 x g for 1 hour followed by incubation for 1 hour at 33°C or 
37°C. The media was then removed and replaced with 2 ml of fresh CGM. Cells were 
incubated at 33°C or 37°C. 
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3.5.3. Cell lysis 
 
At 2, 12, 24, 36 and 48 h post infection for experiments at 37°C and at 2, 12, 24, 36, 
48, 60 and 72 h post infection for experiments at 33°C, media was removed from the 
wells and discarded.  Two millilitres of guanidine thiocyanate (GTC) solution 
containing 1.4 % β-mercapto-ethanol (Sigma, Steinheim, Germany) was added per 
well. This was pipetted up and down multiple times in order to lyse the cells.  The cell 
lysate from each well was transferred to a 15 ml centrifuge tube and the contents of 
each tube was mixed on a vortex mixer for 2 min. The tubes were then centrifuged at 
3000 x g for 30 minutes at 4oC to pellet the chlamydia. The supernatant was decanted 
and the pellet was re-suspended in 200 µl of GTC solution. This suspension was 
transferred to a microcentrifuge tube. These tubes were centrifuged at 13000 x g for 20 
seconds at 4oC. The supernatant was discarded and the pellet was re-suspended in 200 
µl Trisure (Bioline). The chlamydia lysate was transferred to a screw cap 
microcentrifuge tube with 0.1 mm silicon microbeads (Biospec). The lysate was 
vortexed for 1 minute and immediately placed on ice for 2 minutes; this step was 
repeated three times. The microcentrifuge tubes were then stored at -80°C until RNA 
isolation. 
 
 
3.5.4 RNA isolation 
 
The microcentrifuge tubes containing chlamydia lysate were retrieved from the freezer 
and transferred to an icebox. The suspension was centrifuged at 12000 x g for 10 
minutes at 4oC. The supernatants were transferred to sterile 2 ml microcentrifuge tubes, 
which were then allowed to stand at room temperature for 10 minutes. Forty µl cold 
chloroform (Sigma, Steinheim, Germany) was added. The tubes were vigorously mixed 
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by shaking manually for 30 seconds. This was followed by incubation at room 
temperature for 10 min, followed by centrifugation at 12000 x g for 15 minutes at 4oC. 
The yellowish upper aqueous phase containing RNA was transferred to a sterile 2 ml 
tube. Hundred µl cold isopropanol (Sigma, Steinheim, Germany) was added to each 
tube and the contents of the tubes was mixed by inverting three times. The mixtures 
were then incubated at room temperature for 15 minutes followed by centrifugation at 
12000 x g for 15 minutes at 4oC. The supernatant was carefully aspirated without 
disturbing the gel-like RNA pellet. The RNA was washed by re-suspending the pellet 
in 200 µl 75% ethanol prepared in diethyl-pyrocarbonate (DEPC)-treated distilled 
water and this was centrifuged at 7500 x g for 5 minutes at 4oC. The supernatant was 
carefully decanted and the pellet was air-dried for 10 minutes. The RNA was then re-
suspended in 14 µl of RNA-secure using a pipette (10 cycles of aspiration and release). 
The tubes containing RNA were then incubated for 10 min at 60oC in a water bath and 
then placed on ice.   Quantity and purity of the RNA was measured at 260 nm and 280 
nm (260/280) using a NanoDrop 2000C spectrophotometer (Thermo Scientific). 
Thereafter, based on the absorbance readings, DNase treatment was performed 
according to manufacturer’s instructions to purify the RNA. Quantity and purity of the 
RNA was measured again. The quality of the purified RNA was confirmed using 
agarose gel electrophoresis (3.5.4). RNA was stored at -70oC until cDNA synthesis.  If 
cDNA synthesis took place more than one day after RNA isolation, the quality of the 
RNA was confirmed again using agarose gel electrophoresis to check for deterioration. 
 
3.5.5. Agarose gel electrophoresis 
 
The casting tray, combs and rigs were wiped with 70% ethanol and the open ends of 
the casting tray was closed with masking tape.  A 2% agarose gel was prepared by 
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dissolving 4 g of agarose (Seakem®LE Agarose, Lonza) in 200 ml Tris-acetate-EDTA 
(TAE) buffer (1x) (Thermo Scientific). The mixture was allowed to cool till 
approximately 45oC and then poured into a casting tray. A comb was inserted and the 
gel was allowed to solidify (approximately 30 minutes). The comb and masking tape 
were removed and the casting tray containing the gel was then placed in an 
electrophoresis tank.  TAE buffer (1x) was added until the gel was covered 
(approximately 500 ml). Ten µl of isolated and purified RNA to be tested was mixed 
with 3 µl loading dye (containing gel red stain) on a clean piece of ParafilmTM. Each 
mixture was loaded into a well of the gel. The samples were electrophoresed at 100 V 
for 1 hr. The RNA bands were visualized immediately under UV light.  
 
3.5.6. cDNA synthesis 
 
To synthesize single-stranded cDNA from total RNA, the high capacity cDNA reverse 
transcription (RT) kit (Applied Biosystems, Life Technologies) was used according to 
manufacturer’s instructions. Thawed RNA was quantified using a NanoDrop 2000C 
spectrophotometer (Thermo Scientific) and adjusted to 0.2 µg / µl. The kit components 
were allowed to thaw on ice. The 2x RT master mix was then prepared on ice as shown 
in table 3.1. 
Table 3.1: Components used to prepare a 2x RT master mix 
Component  Volume per reaction tube (20 µl reaction) 
10x RT buffer, 1,0 ml 2.0 µl 
25x dNTP Mix (100 mM) 0.8  µl 
10x Random Primers, 1.0 ml 2.0 µl 
Multiscribe Reverse Transcriptase, 50 U/µl 1.0 µl 
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RNase Inhibitor 1.0 µl 
Nuclease free water 3.2 µl 
 
The cDNA reactions were prepared by pipetting 10 μl of 2 x RT master mix and 10 μl 
of RNA sample into a 0.2 ml PCR tube. The tubes were sealed and centrifuged briefly 
to make sure that all fluid was at the bottom of the tube. The tubes were then loaded in 
the thermal cycler (Gene Amp® PCR System 9700, Applied Biosystems). After the RT 
PCR was complete, the cDNA was quantified by measuring the absorbance at 260 nm 
and 280 nm using the Nanodrop spectrophotometer. The cDNA was stored at 2 - 8°C 
for further use. 
 
3.5.7. Quantitative real-time PCR 
 
Custom Taqman® gene expression assays are gene-specific versions of predesigned 
real-time PCR 5’ nuclease Taqman® assays for relative quantification of gene 
expression. The custom assays for groEl-1, incB, pyk-F, tal, omcB and hctA were 
designed and synthesized by Applied Biosystems (ABI). The 16S rRNA gene was used 
as reference gene. The sequences (forward primer: 
5'TCGAGAATCTTTCGCAATGGAC; reverse primer: 
5'CGCCCTTTACGCCCAATAAA; probe: FAM-
AAGTCTGACGAAGCGACGCCGC) were obtained from Goldschmidt et al., 2006. 
Primers and probe for this gene were also synthesized by ABI. The PCR reactions were 
carried out in a final volume of 25 µl as shown in table 3.2. 
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Table 3.2: Components used to prepare QRT-PCR reactions 
Component Volume per 25 µl reaction 
Gene expression master mix (Applied 
Biosystems) 
12.5 µl 
Custom assay mix 
16SrRNA only: 
Forward primer (0.5 µmol/l) 
Reverse primer (0.5 µmol/l) 
FAM-TAMRA Probe (0.4 µmol/l) 
1.25 µl 
 
0.25 µl 
0.25 µl 
0.2 µl 
Nuclease free water 8.25 µl 
Sample (cDNA eluted in nuclease free water) 2.5 µl 
 
MicroAmp® Optical 96-well Reaction Plates (Applied Biosytems) were used for the 
PCR reactions. The plates were centrifuged (250 x g, 20 minutes and 24°C) before 
performing RT-PCR. The amplification and detection was carried out using the ABI 
Prism 7500 Real -Time PCR System (Applied Biosystems). The PCR cycling 
programme consisted of 50 two-step cycles of 15 sec at 95°C, and 1 minute at 60°C.  
Data were presented as the mean cDNA copy number obtained for each gene divided 
by the corresponding mean 16S rRNA values. Relative fold change was calculated 
using the comparative 2 
-CT method. 
 
3.6 Transmission Electron Microscopy (TEM) 
Transmission electron microscopy was performed at the same time points and 
temperatures used in the gene expression experiments to confirm the stage of the 
developmental cycle that the organism was at inside the keratinocytes at each of these 
time points. The results of the gene expression assays were compared with transmission 
electron microscopy done under the same.  
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3.6.1 Monolayer preparation and infection 
 
HaCaT cells were grown in tissue culture flasks. Confluent cells were trypsinised 
(3.1.3) and 1 x 105 cells seeded in each well of a 24 well tissue culture plate containing 
Thermanox coverslips (Nunc) with a diameter of 12 mm. When cells were 
approximately 90% confluent, cells were trypsinized and enumerated (3.1.3 and 3.1.5). 
The residual CCM was aspirated and the monolayer was washed once with PBS. 
Following this, chlamydial growth medium was added. The chlamydial inoculum was 
thawed and diluted to the required concentration with SPG buffer, and inoculated onto 
cells. The cells that were to be incubated at 37oC and 33oC for 2 or 12 hours were 
infected at an MOI of 100 while the cells that were to be incubated at 37oC and 33oC 
longer were infected at an MOI of 10.   For the negative control, 100 µl sterile SPG 
buffer without chlamydia was added. Cells were centrifuged immediately at 1200 x g 
for 1 hour at 37oC and then incubated at 37oC in 5% CO2. The SPG buffer with the 
residual inoculum was removed after 2 hours of incubation and replaced with 1 ml fresh 
CGM. 
 
 
3.6.2 Monolayer processing 
 
At each time point, one monolayer infected with each strain at each of the incubation 
temperatures was fixed and processed for transmission electron microscopy (TEM). 
After washing with EMEM, the coverslips with infected monolayers were transferred 
to a dry sterile 24- well plate using sterile forceps and a dissecting needle. The original 
plate was returned to the incubator, while the harvested coverslips with their cell 
monolayers were processed within the 24-well plate to which they had been transferred. 
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Cells were fixed with 2% gluteraldehyde in EMEM for 30 minutes, and then washed 
with EMEM twice for 5 minutes. The fixed monolayers were covered by a layer of 
sterile EMEM and refrigerated until further processing (no more than 20 hours). The 
preparation process is summarized in table 3.3. In order to embed the fixed cells for 
TEM, a beam capsule was filled with Spurr resin and the coverslip placed on top of the 
beam capsule with the cell-side down and in contact with the resin. This structure was 
incubated at 60°C for 8 hours to allow the resin to solidify. After 8 hours the coverslip 
was removed. 
 
Table 3.3 Processing schedule for TEM 
 
Step Process Solution Temperature Time 
1 Fixation 2% gluteraldehyde in 
EMEM 
24oC 30 min 
2 Wash EMEM 24oC 5 min 
3 Wash EMEM 24oC 5 min 
4 Wash Sodium cacodylate buffer 24oC 5 min 
5 Post- fixation 1% osmium tetroxidea 24oC 1hour 
6 Wash Sodium cacodylate buffer 24oC 5 min 
7 Wash Sodium cacodylate buffer 24oC 5 min 
8 Dehydration 50% ethanol 24oC 10 min 
9 Dehydration 70% ethanol 24oC 10 min 
10 Dehydration 90% ethanol 24oC 10 min 
11 Dehydration 100% ethanol 24oC 10 min 
12 Dehydration 100% ethanol 24oC 10 min 
13 Dehydration 100% ethanol 24oC 10 min 
14 Infiltration Ethanol : Spurr resin 
(1:1)b 
24oC 30 min 
15 Infiltration Spurr resinb 60oC 1 hour 
16 Infiltration Spurr resinb 60oC 1 hour 
17 Embedding Spurr resin 60oC 8 hours 
a
 protected from light  
b
 procedure carried out uncovered to allow polypropylene to evaporate 
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3.6.3 Ultramicrotomy 
 
The section of the resin block containing cells was cut and trimmed to produce a “mesa” 
with a trapezoidal shape. Ultrathin sections (50-60 nm) were cut and collected onto 
uncoated copper 200 mesh grids, then double stained with uranyl acetate and Reynold’s 
lead citrate for 10 minutes respectively (Young and Elliott 1989). Uranyl acetate and 
Reynolds lead citrate were decanted and centrifuged to pellet any debris or solute 
crystals. Grids were floated on a drop of uranyl acetate for 10 minutes, rinsed twice 
with triple distilled water and blotted dry on a filter paper. They were then placed in a 
drop of Reynolds lead citrate, rinsed twice with triple distilled water and blotted dry. 
 
3.6.4 Visualization and photography 
 
Sections were viewed using a Jeol 1010 transmission electron microscope at an 
accelerating voltage of 100 kV. The TEM was interfaced with a Megaview III Software 
Imaging Systems camera unit. Images were captured digitally and measurements 
performed using iTEM analySIS (Germany) image analysing software. 
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CHAPTER 4: RESULTS 
 
4.1 Quantitative real-time PCR 
 
A validation analysis of standard curves for CT method was performed for the six 
selected Chlamydia trachomatis genes. These are groEL-1, incB, pyk-F, tal, hctA and 
omcB. The CT values were plotted vs. log input amount cDNA to create a semi-log 
regression line. The gradients of the regression lines were for groEL-1 -0.0162, for incB 
0.0106, for pyk-F -0.0011, for tal 0.0112, for hctA 0.0261 and for omcB 0.0417 
(Figure1). Since all six values were  0.1, the analysis is valid for all.  
 
Following the validation analysis, relative quantitation of gene expression was 
performed and the mean fold difference was calculated using the comparative 2 
-CT 
method (Biosystems 2004). We analyzed the expression of the six C. trachomatis genes 
using total RNA harvested at 2, 12, 24, 36 and 48 hours post infection for cells 
incubated at 37oC and at 2, 12, 24, 36, 48, 60 and 72 h post infection for cells incubated 
at 33oC. The summary of the gene expression results is given in table 4.1. 
 
The groEL-1 and incB genes were expressed at every time point at both 37oC and 33oC 
for strains L2 434, L2 US151 and strain E (fig.2 A-D). At 37oC, the expression levels 
for groEL-1 (fig.2A) and incB (fig. 2C) were at its highest at 2 hours post infection, and 
then gradually decreased thereafter for all three strains. The expression levels for L2 
434 were considerably higher at 2, 12, 24 and 36 hours post infection compared to L2 
US151. Fig. 2B shows the results for GroEL-1 at 33oC. Like at 37oC, groEL-1 
expression by strain L2 434 was observed at all time points at low levels throughout 
the developmental cycle. GroEL-1 expression levels also remained low up till 12 hours 
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post infection in L2 US151 but with this strain an approximately 10-fold increase was 
observed from 24 hours post infection onwards. At 33oC expression levels of strain E 
varied but without a clear trend.  At 37oC incB expression (fig 2C) was high at 2 hours 
post infection in strain L2 434 but declined rapidly. Strain L2 US151showed low levels 
of expression throughout.  Expression levels of strain E were high during the first 12 
hours post infection but low after that. At 33oC (fig. 2D), incB expression levels of L2 
434 and US151 remained constant throughout the developmental cycle with a peak at 
48 hours for the latter.  In strain E, the expression levels peaked at 12 hours post 
infection, remained high up till 24 hours and decreased thereafter. 
 
At 37oC, pyk-F expression levels (fig. 3A) in both LGV strains were highest at 2 hours 
post infection, then decreased in the period between 2 and 24 hours and remained 
constantly low from 24 hours post infection. Expression levels of pyk-F over time in 
strain E were similar to the LGV strains but at lower levels. In contract to 37oC, pyk-F 
expression levels at 33oC (fig. 3B) remained low between 2 and 12 hours post infection, 
and then increased from 24 hours post infection. As expected pyk-F was detected from 
12 hours post infection with E, but from 24 hours post infection with L2 US151 and 
throughout the developmental cycle for L2 434. Strain L2 434 had the lowest 
expression levels at this temperature. Tal was also detected throughout the 
developmental cycle for all three strains at both temperatures (fig 3C and D) but the 
expression levels differed. Tal expression levels remained constantly low throughout 
the cycle for L2 434 and US151 but were high between 2 and 12 hours post infection 
for E at 37oC (fig. 3C). At 33oC, tal expression was observed at all time points with a 
gradual increase of expression levels till the peak was reached for all three strains at 48 
hours post infection (fig 3D). 
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At 37oC, hctA expression of L2 434 was at its highest level at 2 hours post infection 
and declined gradually till 48 hours post infection. Although there was a similar 
expression by strains L2 US151 and E, the values were lower and the decline less 
outspoken (fig 4A). At 33oC, hctA expression (fig 4B) was detected from 12 hours post 
infection, and then a 2.5-fold increase was observed at 24 hours post infection for L2 
434. Expression levels remained constantly low throughout the developmental cycle 
for L2 US151. HctA expression was also detected from 12 hours post infection, and 
then a 0.5-fold increase was observed at 24 as well as at 72 hours post infection for 
strain E (fig. 4B). At 37oC, omcB expression (fig 4C) was high at 2 hours post infection, 
levels decreased at 12 hours post infection, and then a 5-fold increase was observed at 
24 hours post infection for L2 434. The expression levels remained constantly low 
throughout the developmental cycle for L2 US151. Expression was high between 2 and 
12 hours post infection, and then a 3-fold decrease in expression was observed at 24 
hours post infection for E (fig. 4C). At 33oC, high levels of omcB expression (fig 4D) 
were detected from 24 till 48 hours post infection for L2 434, but remained constantly 
low throughout the developmental cycle for L2 US151 and E.  
 
To verify the observations in HaCaT cells, we performed the same analysis in HeLa 
cells. Table 4.2 summarizes the results of RT-PCR analysis in infected HeLa cells for 
three (groEL-1, pyk-F, hctA) chlamydial genes representing each of the three proposed 
temporal classes of chlamydial gene expression. The results obtained were in keeping 
with the published research as groEL-1 was detected from 2 hours post infection, pyk-
F from 12 hours post infection and hctA from 24 hours post infection (Shaw, Dooley et 
al. 2000). 
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4.2 Transmission electron microscopy (TEM) 
 An ultrastructural analysis was performed using TEM to place transcriptional events 
into context of the C. trachomatis biovar LGV and biovar G developmental cycle, and 
to confirm the stage of the developmental cycle that the organism is in the keratinocytes 
while expressing the various genes.  
 
EBs were about 200 -300 nm in diameter, with a dark highly condensed inner region. 
As differentiation of EB to RB occurred, an increase in size was apparent. RBs were 
about 1 m in diameter and had a pleomorphic shape.  
 
At 37oC and 33oC, both LGV (L2 434 and US151) and G (E) strains presented the 
normal chlamydial replication cycle comprising EB and RB. The ultrastructural events 
observed during C. trachomatis LGV and G developmental cycle at 37oC and 33oC are 
depicted in figures 5, 6 and 7. 
 
Figure 5 shows the ultrastructural events of strain L2 434 at 37oC and 33oC.  Figure 5A 
and B show uninfected HaCaT cells grown at 37oC and 33oC respectively, which 
appeared polygonal in shape and had a centrally located nucleus containing nucleoli. 
Infected HaCaT cells appeared similar to uninfected cells at 2 hours post infection as 
there were no noticeable morphological differences and not much was observed within 
the cells at both temperatures (fig. 5C and D). Strain L2 434 replicated faster at 37oC 
than at 33oC. At 12 hours post infection, there were approximately 26 RBs within the 
inclusion at 37oC (fig. 5E) and only four at 33oC (fig. 5F). As the organisms 
differentiated into mature RBs, an increase in size was apparent. At 12 hours post 
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infection RBs reached mature size at both temperatures and showed evidence of binary 
fission. The inclusions also expanded to accommodate the increasing number of RBs. 
EBs were first seen at 36 hours post infection at 37oC (fig. 5I) compared to 48 hours 
post infection at 33oC (fig.5 L). At 37oC, EBs continued to accumulate within the 
inclusion at 48 hours post infection (fig. 5K). At 33oC, the inclusion looked ruptured as 
there was no definite distinct division between the cytoplasm of the host cell and the 
inclusion matrix at 60 and 72 hours post infection (fig. 5M and N), and fewer EBs were 
still within the inclusion matrix.   
 
Strain L2 US151 (fig. 6) showed similar ultrastructural events as strain L2 434, except 
that at 2 hours post infection at both temperatures (fig. 6C and D) at least one organism 
was seen within the cell, although no increase in size or replication was yet apparent. 
Furthermore, at 60 hours post infection (fig. 6M) a mixture of numerous RBs and EBs 
were still compartmentalized within the inclusion. 
 
Figure 7 shows the ultrastructural events of strain E at 37oC and 33oC. Figure 7 A and 
B show uninfected cells. Similar to strain L2 434, not much was observed at 2 hours 
post infection at both temperatures (fig. 7 C and D). However, at 33oC a new immature 
inclusion was beginning to from at 12 hours post infection (fig. 7F) compared to 37oC 
where the inclusion was already formed and had approximately 7 mature RBs (fig. 7E). 
Similar to strains L2 434 and US151, EBs were first seen at 36 hours post infection at 
37oC (fig. 7I) compared to 48 hours post infection at 33oC (fig. 7L). In contrast to strain 
L2 434, a mixture of RBs and EBs were still compartmentalized within the inclusions 
at 60 and 72 hours post infection (fig. 7M and N) 
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Figure 1: Validation analysis of chlamydial gene standard curves for 
CT method  
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Figure 2: Expression levels of early-cycle genes at 37oC (A, C) and 33oC 
(B, D) detected by quantitative RT-PCR. Values represent the mean fold 
difference (2 -CT) and the error bars indicate the standard error of the 
mean 
39 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
40 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Expression levels of mid-cycle genes at 37oC (A, C) and 33oC 
(B, D) detected by quantitative RT-PCR. Values represent the mean fold 
difference (2 -CT) and the error bars indicate the standard error of the 
mean. 
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Figure 4: Expression levels of late-cycle genes at 37oC (A, C) and 33oC 
(B, D) detected by quantitative RT-PCR. Values represent the mean fold 
difference (2 -CT) and the error bars indicate the standard error of the 
mean. 
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Table 4.1: Expression of chlamydial genes in HaCaT cells at 37 oC and 
33oC 
 
Expression peak time point (hours post infection) 
37oC 33oC 
Gene Function L2 434 US151 E L2 434 US151 E 
GroEL-1 Chaperonin (60 
kDa) 
– Stabilizes 
cellular 
proteins 
2 - 12 Continuous 
expression 
2 -12 Continuous 
expression 
48 Continuous 
expression 
IncB Inclusion 
membrane 
protein 
– Mediates 
interaction 
between 
chlamydia and 
the host cell 
2 Continuous 
expression 
 Continuous 
expression 
48 12 
Pyk-F Pyruvate kinase 
– Energy 
metabolism 
during 
glycolysis 
pathway 
2 2 2 -12 Continuous 
expression 
24 – 72 24 -72 
Tal Transaldolase 
– Energy 
metabolism 
during the 
pentose 
phosphate 
pathway 
Continuou
s 
expression 
Continuous 
expression 
2 -12 24 -60 2 -48 2 -48 
HctA Histone-like 
protein 
– Condensation 
of 
chromosome 
during  the 
differentiation 
of ERs to EBs 
2 -12 2 -36 2 and 
24 
24 2 – 48 72 
OmcB Cysteine-rich 
OMP (60 kDa) 
– Ensures Eb 
rigidity 
2, 24 and 
36 
Continuous 
expression 
2 – 12 24 – 48 Continuous 
expression 
24 
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Table 4.2: Temporal expression of selected chlamydial genes in HeLa 
cells infected with L2 at 37oC 
 
 Time (hours) post infection 
Gene 2 12 24 36 48 
groEL-1 + + + + + 
Pyk-F - + + + + 
hctA - - + + + 
+, Amplification detected 
-, No amplification detected 
 
 
 
 
 
L2 434 
 37oC 33oC 
 
 
Negative 
control 
A B 
 
 
 
2h 
C 
 
D 
 
45 
  
 
 
 
12h 
E  F 
 
 
 
24h 
G H 
 
 
 
36h 
I 
 
J 
 
 
 
 
48h 
K L 
46 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: TEM micrographs of HaCaT cells infected with C. trachomatis 
L2 434 demonstrating differentiation, growth, division and 
redifferentiation at 37oC and 33oC over the course of the developmental 
cycle. Uninfected (A), 2h (C), 12h (E), 24h (G), 36h (I) and 48h (K) post 
infection at 37oC. Uninfected (B), 2h (D), 12h (F), 24h (H), 36h (J), 48h 
(L), 60h (M) and 72h (N) Cultures in C-E and D-F were infected at an MOI 
of 100 to increase the likelihood of visualizing organisms in thin sections. 
Cultures in G-K and H-N were infected at an MOI of 10. Bar, 500 nm. 
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Figure 6: TEM micrographs of HaCaT cells infected with C. trachomatis 
E demonstrating differentiation, growth, division and redifferentiation at 
37oC and 33oC over the course of the developmental cycle. Uninfected (A), 
2h (C), 12h (E), 24h (G), 36h (I) and 48h (K) post infection at 37oC. 
Uninfected (B), 2h (D), 12h (F), 24h (H), 36h (J), 48h (L), 60h (M) and 
72h (N). Cultures in C-E and D-F were infected at an MOI of 100 to 
increase the likelihood of visualizing organisms in thin sections. Cultures 
in G-K and H-N were infected at an MOI of 10. Cultures in G-N were 
infected at an MOI of 10. Bar, 500 nm 
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Figure 7: TEM micrographs of HaCaT cells infected with C. trachomatis 
US151 demonstrating differentiation, growth, division and 
redifferentiation at 37oC and 33oC over the course of the developmental 
 
 
 
 
36h 
 
 
I J 
 
 
 
 
 
48h 
K L 
 
 
 
 
60h 
 
 
 
M 
 
 
 
 
72h 
 
N 
51 
  
cycle. Uninfected (A), 2h (C), 12h (E), 24h (G), 36h (I) and 48h (K) post 
infection at 37oC. Uninfected (B), 2h (D), 12h (F), 24h (H), 36h (J), 48h 
(L), 60h (M) and 72h (N). Cultures in C-E and D-F were infected at an 
MOI of 100 to increase the likelihood of visualizing organisms in thin 
sections. Cultures in G-K and H-N were infected at an MOI of 10. Cultures 
in G-N were infected at an MOI of 10. Bar, 500 nm. 
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CHAPTER 5: DISCUSSION 
 
This study contributes to understanding the difference pathogenicity of the LGV biovar 
of C. trachomatis and its G (enital) biovar. LGV infection begins in the skin and the 
temperature of the skin is + 33oC. As the infection progresses to the secondary stage in 
the lymph nodes the temperature to which the chlamydia are exposed changes to the 
body core temperature which is 37oC. Most research on the behaviour of chlamydia in 
cell culture, irrespective of the biovar, has been done at 37oC. In addition, this research 
has been carried out in cell lines that are not its primary target cell and with reference 
strains of C. trachomatis whose behaviour may have been transformed by many years 
of in vitro propagation (Joubert and Sturm, 2011). Shaw et al. (2000), Belland et al. 
(2003) and Nicholson et al. (2003) performed genomic transcriptional analysis during 
the chlamydial developmental cycle. However, they restricted their analysis to one 
serovar, and thus, no information is available on comparative gene expression between 
serovars. Joubert and Sturm (2011) developed a model in which C. trachomatis is 
grown in human keratinocytes at 37 and 33 °C. They used fresh clinical isolates and 
the three ATCC LGV reference strains L1, L2 and L3. They concluded that this model 
more closely represents the conditions present at the primary infection site in LGV than 
other models published in the literature. These recommendations were applied in this 
study. 
 
As Joubert and Sturm (2011), we used the HaCaT cell line, which is an immortalized 
human keratinocyte cell line that has a similar differentiation pattern to that of a normal 
keratinocyte (Boukamp, Breitkreutz et al. 1994). We also used clinical LGV isolate (L2 
US151) in addition to an ATCC reference strain (L2 434). A clinical isolate of the 
Genital biovar (strain E) was used for comparison purposes. In addition, we used TEM 
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to correlate the transcriptional events and to confirm the stage of the organism in the 
developmental cycle at 37oC and 33oC 
 
The chlamydial developmental cycle has been well characterized microscopically. 
However, the signals that stimulate conversion from EB to RB and vice versa are so far 
unknown. In addition, the mechanisms associated with the regulation of intracellular 
development are poorly understood (Wickstrum, Sammons et al. 2013). It has been 
shown that the synthesis of numerous proteins occurs throughout the chlamydial 
developmental cycle, while other proteins are associated with mid- and late-stage 
differentiation (Shaw, Dooley et al. 2000). This pattern of protein synthesis is consistent 
with the structural and functional characteristics of the chlamydial developmental cycle 
(Rosario and Tan 2016).  
 
The previous identification of temporally regulated genes implicates an ordered system 
of developmental regulation and suggests that the developmental cycle is ultimately 
regulated at the transcriptional level (Shaw, Dooley et al. 2000, Belland, Zhong et al. 
2003, Nicholson, Olinger et al. 2003). Early-, mid- and late-cycle genes represent a 
subset of genes that are important in understanding key events in the differentiation 
processes that control the developmental cycle (Belland, Zhong et al. 2003). 
 
In this study we aimed to investigate the effect of temperature on chlamydial temporal 
gene expression in human keratinocytes. 
 
Two early-cycle genes were quantified by RT-PCR. These are the inclusion protein 
gene incB and the chaperonin gene groEL-1. The findings confirmed these as early-
cycle genes as they were expressed at every time point of the developmental cycle from 
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2 hours post infection, thus supporting previous reports using different experimental 
procedures. The family of inclusion proteins expressed during the chlamydial 
developmental cycle play an important role in modifying the inclusion membrane to 
support chlamydial intracellular survival and growth (Belland, Zhong et al. 2003). 
Modification and extension of this membrane takes place throughout the cycle but will 
decrease in the late stage.  
At 37oC, L2 434 showed an over 30-fold increase in incB expression level at 2 hours 
post infection, compared to L2 US151 in which a constantly lower level of expression 
was observed. IncB is one of a set of Inc proteins and we propose that our clinical LGV 
isolate uses one or more Inc proteins other than IncB. This difference may be on the 
account of the modification of strain LGV 434 during numerous passages in cell 
culture. The immediate increase in level of incB expression at 2 hours post infection by 
LGV 434 was not seen at 33oC which indicates that modification of the nascent 
inclusions occurs at a faster rate at 37oC than at 33oC. This was in keeping with the 
chlamydial growth rate observed using the TEM.  Furthermore, at 33oC both L2 434 
and US151 showed a fairly constant level of incB expression throughout the 
developmental cycle. This finding is due, in part, to the fact that LGV reference strains 
have been proved to grow significantly faster at 37oC than 33oC in HaCaT cells(Joubert 
and Sturm 2011). At both temperatures, incB expression levels peaked at 12 hours post 
infection for strain E. The difference in the pattern of gene expression observed for 
strain E could be correlated with the fact that the primary target for G strains are 
epithelial cells of the genital tract, and in this study keratinocytes were used.  
 
At 37oC and 33o C, groEL-1 expression levels remained fairly constant between 2 and 
36 hours post infection for all tested strains. However, strain E at 37oC and L2 US151 
at 33oC showed increased groEL-1 expression levels at 48 hours post infection.  GroEL-
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1 is known to increase during nutrient deprivation (Karunakaran, Noguchi et al. 2003), 
which could be the case late in the cycle and thus have resulted in these findings.  
 
The C. trachomatis genome contains genes that code for enzymes of glycolysis and 
pentose phosphate pathway enzymes and the genes encoding these enzymes have been 
named the mid-cycle chlamydial genes (Shaw, Dooley et al. 2000, Gérard, Freise et al. 
2002). In the mid-cycle a number of cellular processes take place including energy 
metabolism, DNA replication and repair, protein folding and type III secretion system 
(TTSS). Expression of pyk-F of the glycolysis pathway and tal of the pentose phosphate 
pathway were analyzed in this study as representatives of the mid-cycle genes.  
The RT-PCR analysis indicates that the proteins required for energy metabolism are 
present throughout the chlamydial developmental cycle in keratinocytes at 37oC and 
33oC. However, the two genes studied are expressed at different levels amongst the 
tested chlamydial strains. Pyk-F expression was most abundant at 2 hours post infection 
at 37oC in all tested chlamydial strains, indicating that energy is required immediately 
following invasion of chlamydia into the keratinocytes. This differs from what is seen 
in HeLa cells with strain E where no expression of pyk-F was seen in the early phase 
(Table 4.2). Tal on the other hand was expressed the highest at 12 hours post infection 
for strain E, which correlates with rapid growth and division of RBs. This is consistent 
with the electron microscopic observations (Fig. 7E). At 33oC, the metabolically active 
stage of the cycle was delayed, as both pyk and tal were most abundant from 24 hours 
post infection. This was also consistent with the TEM observations in which the 
metabolically active RB form was only observed from 24 hours post infection at 33oC 
(Fig. 7H).  
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Two late-cycle genes that have been reported to be expressed from 24 hours post 
infection were also analyzed.  These are hctA that encodes chlamydial histone-like 
protein and mediates chromosomal condensation during the differentiation of RBs to 
EBs, and omcB that encodes cysteine rich outer membrane protein that interact with the 
MOMP to form this complex which involves extensive protein cross linking through 
the formation of cysteine bonds (Belland, Zhong et al. 2003).  
 
At 37oC an increase in hctA expression was observed at 2 hours post infection and 
decreased by 1- fold at 12 hours post infection for L2 434 and serovar E. This could be 
due to the fact that at 2 hours post infection chlamydia still has highly condensed 
chromosome. This is supported by the high hctA expression in the early phase. 
Condensed chromatin of EB is dispersed as differentiation into pleomorphic RB occurs, 
and as this occurs the expression of hctA is downregulated (Tattersall, Rao et al. 2012). 
hctA expression levels remained fairly constant form 2 to 36 hours post infection for 
L2 US151. The fact that this was isolated from an ulcer in primary stage of infection 
might have affected the normal regulation of ihtA and hctA expression. Expression of 
hctA is tightly regulated and is repressed by the small non-coding RNA, IhtA until RB 
to EB redifferentiation (Grieshaber, Grieshaber et al. 2006). IhtA regulate the 
translation of a target mRNA during specific developmental stages. IhtA is transcribed 
early in the infection process to repress expression of hctA. Late in infection, IhtA 
transcription decreases allowing HctA synthesis to occur and RB to EB differentiation 
to proceed (Altuvia 2004, Grieshaber, Grieshaber et al. 2006). A different expression 
pattern was observed at 33oC; hctA expression was abundant from 24 hours post 
infection for L2 434 and US151, although hctA was still expressed in low levels at 2 
and 12 hours post infection. Strain E had two expression peaks of hctA, at 24 and 72 
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hours post infection. This suggests that by 72 hours post infection strain E was 24 hours 
in a second cycle. Previous studies reported that hctA is not expressed until 24 hours 
post infection in HeLa cells. However, our study shows that in keratinocytes hctA is 
expressed throughout the chlamydial developmental cycle but the level of expression 
increases from 24 hours post infection.  
 
Like hctA, at 37oC strain L2 434 showed high omcB expression level at 2 hours post 
infection. At 12 hours post infection the expression level was suppressed, but 
upregulated again at 24 hours post infection. These findings suggest that chlamydia is 
still in a EB form at 2 hours post infection in keratinocytes, as omcB is only found in 
EBs as the component of the disulphide-linked outer membrane protein complex that 
confers structural stability to EBs (Shaw, Dooley et al. 2000).  L2 US151 however 
showed a different expression pattern compared to L2 434. OmcB expression level 
remained fairly constantly low throughout the chlamydial developmental cycle. This 
was the case for hctA expression as well. This could mean that the clinical L2 isolates 
circulating have a different regulatory system for gene expression as the laboratory L2 
strain. Another possibility is the fact that the two L2 isolates studied were isolated at 
different sites of infection could have affected the gene expression regulatory system. 
Lastly, in our population LGV presents in the primary stage as a painful genital ulcer 
without the tendency to resolve spontaneously. This could mean that there is a genetic 
difference between LGV strains that is responsible for this difference in clinical 
presentation (Sturm, Moodley et al. 2005). Strain E also showed a different pattern of 
omcB expression; fairly low expression levels were observed in the late-cycle compared 
to early- and mid-cycle. These findings suggest that chlamydial gene expression differs 
amongst the target cells for different chlamydial biovars. 
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At 33oC, Both L2 reference strains and strain E only expressed omcB from 24 hours 
post infection and increased at 36 hours post infection. This was consistent with the 
TEM, which showed numerous EBs at 36 hours post infection. These findings are the 
same as previously published reports in HeLa cells at 37oC. At 60 and 72 hours post 
infection omcB expression was suppressed in L2 434 and US151, indicating that the L2 
chlamydial life cycle is completed by 48 hours post infection in keratinocytes at 33oC. 
Furthermore, strain E showed some expression of the late cycle genes at 60 and 72 
hours post infection, indicating that the developmental cycle for strain E can go on up 
to 72 hours. This was also consistent with the TEM, which showed numerous EBs that 
were still compartmentalized within the inclusion at 60 and 72 hours post infection. 
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CHAPTER 6: CONCLUSIONS 
 
Mid- and late-cycle chlamydial gene expression levels in keratinocytes are different to 
the published research conducted in HeLa cells. The mid- and late-cycle genes were 
expressed throughout the chlamydial developmental cycle in keratinocytes. These 
observations were reproducible. Furthermore, the reliability of the methods applied was 
confirmed by performing the same experiments in HeLa cells and in our hands results 
in HeLa cells were as published. 
 
C. trachomatis metabolism rate is less at 33oC than at 37oC. This was indicated by 
decreased pyk-F and tal expression levels at 33oC. This was also confirmed by TEM in 
which the metabolically active RB form and redifferentiation to EBs was delayed at 
33oC. This supports the observation in this and a previous study (Joubert and Sturm 
2011) that C. trachomatis replicates faster at 37oC than at 33oC. 
 
This study confirms that temperature has an effect on the level of chlamydial gene 
expression when grown in keratinocytes. This is important for further studies on the 
pathogenesis of LGV.  
 
At 2 hours post infection chlamydia still retains its EB structural conformation in 
keratinocytes at 37oC. This was indicated by high expression levels of late-cycle genes 
at 2 hours post infection at 37oC. 
 
The L2 reference strain 434 is different than the clinical L2 US151as indicated by the 
difference in the gene expression pattern. There are several explanations for this. The 
reference strain could have undergone genetic changes during numerous passages in 
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vitro, gene expression patterns could differ between isolates from ulcers (L2 US151) 
and those from lymphnode aspirates (L2 434) or current LGV strains could differ from 
historical strains since the clinical presentation differs from the textbook description. 
This last difference could be restricted to strains circulating in the KZN population or 
be more general. 
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APPENDIX A – REAGENTS AND MEDIA 
 
Phosphate buffered saline (PBS) (Dulbecco A) 
5 PBS tablets (Oxoid) 
500ml-distilled water 
 
Five PBS tablets were dissolved in 500ml autoclaved distilled water. The PBS was 
autoclaved at 121oC for 10 minutes, then decanted into 20ml aliquots and refrigerated 
until use. 
 
0.05% EDTA 
0.05g EDTA 
1 PBS tablet 
100ml-distilled water 
 
One PBS tablet and 0.05g EDTA were dissolved in approximately in 80ml autoclaved 
distilled water. The pH was adjusted to approximately 7.4 using 7.5% sodium 
bicarbonate and the volume brought up to 100ml. The solution was autoclaved at 121oC 
for 10 minutes, pipetted into 1ml aliquots and refrigerated until use. 
 
GTC 
5 M guanidinum thiocyanate (60 g/100 ml) 
0.5% sodium-N-lauryl sarcosine (0.5 g/100 ml) 
25 mM tri-sodium citrate (1 g/100 ml) 
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0.1 M 2-mercaptoethanol (BME) (0.7 ml/100 ml) 
 
60 g of 5 M GTC, 0.5 g of 0.5% sodium-N-lauryl sarcosine and 1 g of 25 mM tri-
sodium citrate were dissolved in 100 ml autoclaved distilled water. The solution was 
left over night to dissolve. On the day of use, 0.7 ml of 0.1 M 2-mercaptoethanol was 
added to the solution. 
 
2 % agarose gel 
4 g agarose 
200 ml 1x TAE buffer 
 
4 g of agarose was dissolved in 200 ml 1 x TAE buffer swirling and heating in the 
microwave. The mixture was allowed to cool then poured into the casting tray. 
 
HaCaT cell freezing fluid 
 
30ml RPMI-1640 with L-glutamine and HEPES 
10ml glycerol  
10ml FBS 
 
Ten milliliters of glycerol and 10ml of FBS were added to 30ml of RPMI-1640 and the 
solution filter-sterilized into a sterile container. 
 
Sucrose-Phosphate-Glutamate Buffer (SPG) 
Sucrose 
KH2PO4 
74 
  
Na2HPO4.7H2O 
Glutamic acid 
Distilled water 
 
The sucrose, KH2PO4, Na2HPO4.7H2O and glutamic acid were dissolved in 
approximately in 400ml autoclaved distilled water, the pH was adjusted to 
approximately 7.4 using 7.5% sodium bicarbonate and the volume brought up to 500ml. 
The solution was filter sterilized through a 0.22Lm filter, then aliquoted and stored at -
20 oC until use. 
 
2% Glutaraldehyde Solution 
 
4 ml 25% glutaraldehyde 
48ml EMEM 
 
Glutaraldehyde was added to EMEM and mixed thoroughly 
 
Spurr resin 
4.1 g 4221-3, 4-Epoxycyclohexanemythyl 3, 4-epoxycyclohexaminecarboxylate (ERL) 
5.9 g Nonenyl succinic anhydride (NSA) 
1.43 g 736-Didlycidyl ether (DER) 
0.1 g Dimethylaminoethanol (DMAE) 
 
ERL, NSA and DER were added together and allowed to mix for 15 minutes. 
Thereafter, DMAE was also added and allowed to mix for a further 15 minutes 
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Lead citrate 
1.33 g lead nitrate 
1.76 g sodium citrate 
8 ml NaOH 
50 ml distilled water 
 
Lead nitrate and sodium citrate were added to 30 ml distilled water in a 50 ml capacity 
stopped flask. The solution was mixed by shaking for 1 minute. The solution was then 
allowed to stand for 30 minutes, shaking at intervals. 8 ml of NaOH was also added and 
the solution was made up to 50 ml with distilled water. The solution was allowed to 
stand until clear before use.  
 
Uranyl citrate 
2 % uranyl citrate was prepared by dissolving 2 g of uranyl citrate powder in 100 ml 
distilled water. It was centrifuged for 15 minutes and refrigerated until required. 
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APPENDIX B – CALCULATIONS 
 
1. Validation experiment calculations  
For a valid CT calculation, the efficiency of the target amplification must be 
approximately equal. This is determined by looking at how CT varies with template 
dilution 
 
 
E.g. Table 1: CT calculations for the validation experiment 
Input mount 
cDNA (ng) 
Log of input 
amount: ng  
cDNA 
groEL-1 
average CT 
16SrRNA 
average CT 
CT 
groEL-1 – 16SrRNA 
100 2 26.76 23.77 2.99 
10 1 30.45 27.56 2.88 
1 0 33.45 30.15 2.97 
0.1 -1 33.12 33.62 2.81 
0.01 -2 38.46 35.35 3.11 
 
For a passing validation experiment, the absolute value of the slope should be  0.1. 
The equation of the regression line is displayed on the graph. The slope of the line is 
“m” in the equation. 
Y = mx + b 
 
2. The comparative CT (CT) calculations 
Step 1: The mean CT and standard deviation values of the replicate sample were 
calculated. 
 
CT = CT (target) – CT (reference) 
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Step 2: The CT values were calculated. 
 
The CT values were calculated by: 
 
E.g. the average reference gene 16SrRNA CT 
value was subtracted from the CT value of target gene groEL-1 and yielded the value 
of -5.42 
GroEL-1 CT = 29.73 – 35.15  
                      = -5.42 
 
Step 3: The standard deviations for the CT values were calculated 
 The standard deviation of the CT value was calculated from the standard 
deviations of the target and reference values using the formula: 
S = (S1 
2 + S2 
2) 1/2; where X1/2 is the square root of X and S = standard deviation 
 
E.g. to calculate the standard deviation of groEL-1 CT value: 
S1 = 0.12 and S2 = 0.21 
S1 
2 = 0.01 and S2 
2 = 0.04 
S = (0.01 + 0.04) ½ 
S = 0.23 
 
Therefore, groEL-1 CT = (29.73  0.01) – (35.15  0.21) 
                                       = -5.42 0.23 
 
Step4: Calculate the CT value 
The CT value was calculated by: 
CT = CT test sample - CT calibrator sample 
For example, subtracting the CT calibrator groEL-1 (from the validation 
experiment) from the CT of groEL-1 (test sample) yields the value of 0.28 
CT = CT target - CT reference 
78 
  
CT = 3.23 – 2.95 = 0.28 
 
Step5: Incorporating the standard deviation of CT values into the fold-
difference. 
 Fold-differences calculated using the CT are expressed as a range, which is 
the result of incorporating the standard deviation of the CT into the fold-
difference calculation. 
 The range for target is calculated by: 
2-
Ct with CT + s and CT –s, where s is the standard deviation of the 
CT value 
For example, groEL-1 at 33oC, 2h post infection had a 0.71 to 0.97 fold-
difference in expression relative to the calibrator groEL-1. 
CT +s = 0.28 + 0.23 = 0.51 
2-
Ct = 2-(0.51) = 0.71 
 
And  
 
CT -s = 0.28 - 0.23 = 0.05 
2-
Ct = 2-(0.05) = 0.97 
 
Mean = 0.84 
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APPENDIX C – RAW DATA 
 
1. HaCaT 37oC CT and standard deviation values 
 16SrRNA CT values 
 L2 E US151 
 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 
run1 41,21 
42,2
4 
23,9
6 
22,9
9 
34,3
2 
35,9
2 
34,8
9 
21,7
3 
19,3
5 
33,8
5 34,89 
38,9
8 
23,9
9 
23,5
3 
33,6
9 
run1 41,22 
41,1
0 
23,9
9 
23,3
5 
35,3
7 
35,0
7 
34,7
7 
21,6
2 
18,9
7 
34,2
5 34,92 
39,2
6 
24,0
6 
23,5
2 
33,8
9 
run1 42,17 
41,0
1 
24,3
3 
23,2
4 
35,6
0 
36,0
8 
34,7
0 
21,7
8 
18,7
8 
33,8
9 35,16 
38,0
2 
23,9
2 
23,3
2 
33,7
2 
run2 45,17 
42,8
6 
23,0
9 
24,6
1 
28,5
5 
37,0
7 
38,1
9 
24,1
5 
19,9
7 
36,1
2 45,64 
40,9
5 
26,8
2 
26,6
3 
33,4
3 
run2 41,29 
40,4
4 
22,6
6 
24,5
6 
28,2
5 
37,4
7 
37,7
8 
23,9
5 
20,0
2 
36,3
6 
Undetermine
d 
41,5
5 
26,7
7 
26,8
7 
33,1
7 
run2 42,06 
42,8
6 
22,9
5 
24,5
6 
28,4
1 
37,4
5 
37,1
7 
24,0
5 
19,5
7 
36,4
6 
Undetermine
d 
41,5
5 
26,6
1 
26,9
5 
32,8
3 
run3 
Undetermine
d 
40,9
5 
25,6
5 
26,4
7 
33,5
1 
39,1
7 
36,3
0 
28,0
1 
26,9
9 
36,1
3 45,97 
41,7
3 
27,5
4 
26,9
1 
35,1
9 
run3 45,02 
40,3
2 
25,3
6 
26,6
7 
33,6
8 
38,9
8 
35,9
7 
27,8
9 
26,7
8 
36,4
3 
Undetermine
d 
43,5
9 
27,7
4 
27,4
0 
35,5
7 
80 
  
run3 44,25 
40,3
6 
25,4
2 
26,6
5 
33,6
7 
38,4
9 
36,3
0 
26,9
0 
27,0
6 
36,2
3 
Undetermine
d 
41,9
1 
27,2
4 
27,1
4 
35,4
5 
 
 
 16SrRNA standard deviation 
 L2 E US151 
 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 
run1 0,55 0,69 0,21 0,18 0,69 0,54 0,10 0,09 0,14 0,22 0,15 0,65 0,07 0,12 0,11 
run2 2,05 1,40 0,03 0,22 0,15 0,22 0,52 0,10 0,35 0,18   0,35 0,11 0,17 0,30 
run3 0,55 0,35 0,15 0,11 0,09 0,35 0,19 0,61 0,15 0,15   1,03 0,26 0,24 0,19 
 
 
 
 IncB CT values 
 L2 E US151 
 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 
run1 
Undetermine
d 
Undetermine
d 
31,9
8 
31,4
9 
40,0
1 
38,6
5 
38,0
8 
28,9
6 
31,4
6 
39,6
0 
41,2
5 
41,3
4 
28,9
7 
37,6
0 
31,7
4 
run1 
Undetermine
d 
Undetermine
d 
31,8
5 
31,3
4 
40,4
2 
38,9
8 
37,5
8 
29,1
3 
31,6
8 
40,8
5 
42,2
0 
41,5
4 
28,3
4 
37,9
1 
31,8
5 
run1 
Undetermine
d 
Undetermine
d 
31,6
3 
30,9
1 
41,2
7 
39,1
1 
38,2
5 
29,1
1 
31,5
8 
40,3
3 
42,4
5 
40,8
3 
29,2
1 
37,9
3 
31,9
7 
run2 37,20 
Undetermine
d 
32,5
8 
32,3
4 
32,1
0 
37,6
0 
39,5
3 
26,1
8 
30,1
4 
38,3
5 
34,7
7 
37,0
1 
26,9
7 
26,7
9 
28,0
6 
run2 38,07 
Undetermine
d 
31,9
7 
32,2
8 
31,6
5 
37,6
8 
40,4
0 
26,2
5 
29,8
9 
38,4
8 
34,7
3 
36,9
0 
26,9
6 
26,5
9 
27,9
9 
81 
  
run2 38,37 
Undetermine
d 
32,4
2 
32,0
0 
31,6
7 
37,1
9 
39,9
6 
26,0
5 
29,8
6 
38,7
9 
34,9
6 
37,0
5 
27,0
1 
26,5
9 
28,0
6 
run3 
Undetermine
d 
Undetermine
d 
31,9
9 
22,1
8 
40,0
2 
35,9
2 
34,9
7 
32,3
9 
28,1
6 
35,3
5 
38,9
7 
36,9
6 
27,1
9 
27,4
8 
34,5
5 
run3 
Undetermine
d 
Undetermine
d 
31,7
1 
22,1
8 
39,9
6 
35,8
1 
34,9
4 
32,8
2 
28,5
0 
35,3
1 
39,2
1 
36,4
0 
27,1
7 
27,8
6 
34,1
4 
run3 
Undetermine
d 
Undetermine
d 
31,8
2 
21,7
2 
39,0
4 
35,9
5 
34,5
7 
32,7
7 
28,5
9 
35,3
8 
39,2
3 
36,4
3 
27,1
1 
27,8
6 
34,4
2 
 
 
 IncB standard deviation 
 L2 E US151 
 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 
run1     0,35 0,35 0,35 0,23 0,35 0,09 0,11 0,63 0,63 0,37 0,45 0,18 0,11 
run2 0,61   0,32 0,18 0,26 0,26 0,43 0,10 0,15 0,22 0,12 0,08 0,03 0,12 0,04 
run3     0,14 0,34 0,54 0,07 0,22 0,24 0,23 0,04 0,15 0,32 0,04 0,19 0,21 
 
 
 
 
 
 
 
 Pyk-F CT values 
 L2 E US151 
 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 
run1 37,56 37,41 24,92 23,96 34,58 33,58 33,92 22,68 29,05 33,10 35,92 37,10 25,52 24,90 34,13 
82 
  
run1 38,40 37,98 25,05 23,96 33,51 33,69 33,73 22,83 28,85 33,04 35,56 36,31 25,61 24,86 34,30 
run1 37,82 37,49 25,14 23,86 35,27 34,10 33,83 22,78 29,08 33,07 35,49 36,77 25,59 24,88 34,37 
run2 38,44 38,70 24,93 23,82 33,96 34,95 35,94 24,66 28,00 35,05 38,58 39,73 27,55 26,82 36,24 
run2 37,93 38,61 24,78 23,75 34,03 35,42 36,18 24,53 28,10 35,46 38,01 39,74 27,65 26,93 36,51 
run2 37,81 38,20 24,91 23,66 34,34 35,64 36,34 24,69 27,91 35,72 38,14 38,40 27,65 26,76 37,24 
run3 42,98 40,08 25,48 25,91 36,31 35,99 36,35 27,62 27,23 35,50 37,98 39,72 27,26 26,73 36,13 
run3 39,53 38,93 25,47 25,87 36,74 35,97 36,94 28,27 27,28 35,19 38,41 39,82 27,19 26,62 35,89 
run3 39,36 38,78 25,48 25,93 36,43 35,41 37,26 27,63 27,05 35,39 38,94 38,65 27,23 26,61 36,47 
 
 
 Pyk-F standard deviation 
 L2 E US151 
 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 
run1 0,43 0,69 0,11 0,06 0,89 0,27 0,10 0,08 0,05 0,03 0,23 0,40 0,05 0,02 0,13 
run2 0,33 0,27 0,08 0,08 0,21 0,35 0,20 0,09 0,06 0,34 0,30 0,77 0,06 0,09 0,52 
run3 2,04 0,71 0,01 0,03 0,22 0,33 0,46 0,38 0,12 0,16 0,48 0,65 0,03 0,07 0,30 
 
 
 
 
 
 
 
 Tal CT values  
 L2 E US151 
 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 
83 
  
run1 
Undete
rmined 
Undete
rmined 29,85 29,90 38,31 35,92 35,68 27,26 30,41 37,53 38,51 38,84 26,54 33,65 29,43 
run1 
Undete
rmined 
Undete
rmined 29,19 29,77 39,25 36,10 35,88 26,94 30,06 37,44 38,40 39,91 26,35 33,81 29,60 
run1 
Undete
rmined 
Undete
rmined 29,93 29,47 
Undete
rmined 35,75 35,52 26,84 30,25 38,01 38,62 38,91 26,50 33,40 30,17 
run2 38,70 
Undete
rmined 29,73 29,81 39,70 35,11 38,28 23,47 29,36 36,17 32,81 34,26 25,11 23,87 26,24 
run2 39,38 
Undete
rmined 29,49 29,35 40,54 35,49 38,74 25,18 29,10 36,14 32,67 34,91 24,94 24,57 25,93 
run2 41,93 
Undete
rmined 29,83 29,35 40,17 34,92 37,45 
Undete
rmined 29,05 35,93 32,20 34,14 25,10 24,69 25,82 
run3 41,72 
Undete
rmined 28,93 29,68 37,91 33,52 33,54 30,21 26,01 33,00 36,93 34,84 25,40 26,27 32,91 
run3 40,84 
Undete
rmined 29,09 29,57 38,31 33,47 32,33 30,07 26,24 32,91 35,92 34,69 25,89 25,94 32,49 
run3 41,85 
Undete
rmined 29,01 29,28 37,09 33,54 32,51 29,90 26,01 32,70 35,79 34,37 25,84 26,39 32,55 
 
 
 
 
 
 
 Tal  standard deviation 
 L2 E US151 
 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 
84 
  
run1 1,48  0,07 0,14 0,79 0,18 0,18 0,22 0,18 0,30 0,11 0,60 0,10 0,21 0,39 
run2 1,70   0,18 0,27 0,42 0,29 0,65 1,22 0,17 0,13   0,42 0,28 0,45 0,22 
run3 0,19  0,08 0,28 0,62 0,04 0,65 0,16 0,13 0,16   0,24 0,27 0,23   
 
 
 
 hctA CT values 
 L2 E US151 
 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 
run1 42,12 42,60 25,92 25,33 40,61 37,31 37,36 22,90 31,39 35,10 40,32 41,27 26,22 26,12 36,71 
run1 43,95 43,67 26,02 25,62 40,48 37,82 36,93 23,80 31,65 35,52 39,73 40,89 26,35 26,06 36,98 
run1 42,73 41,64 25,33 25,14 39,49 37,70 36,67 23,58 31,22 35,40 40,00 40,86 26,68 25,73 37,01 
run2 42,42 41,56 24,87 24,59 35,97 38,97 41,12 25,53 29,96 38,69 44,12 43,61 28,85 28,93 39,24 
run2 42,70 41,93 24,63 24,59 36,71 38,04 39,45 25,91 29,93 38,52 
Undete
rmined 43,51 28,81 29,03 39,31 
run2 43,96 41,02 25,03 24,46 36,59 40,17 40,02 26,16 29,94 38,54 43,80 42,66 29,27 28,72 40,32 
run3 44,92 41,94 25,93 27,93 39,24 39,77 40,42 28,30 29,45 37,93 46,93 43,90 27,96 28,22 38,13 
run3 
Under 
timed 42,79 26,37 27,85 39,24 39,76 41,02 27,76 29,47 38,28 45,35 43,93 28,16 28,26 38,26 
run3 43,97 42,54 26,45 27,77 39,51 39,68 40,92 29,41 29,19 38,28 45,36 
Undete
rmined 28,16 27,98 37,97 
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 hctA standard deviation 
 L2 E US151 
 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 
run1 0,89 0,89 0,89 0,89 0,89 0,27 0,35 0,47 0,24 0,22 0,29 0,23 0,24 0,21 0,17 
run2 0,82 0,46 0,20 0,07 0,40 1,07 0,85 0,32 0,13 0,09 0,23 0,52 0,25 0,16 0,60 
run3 0,67 0,44 0,28 0,08 0,16 0,05 0,32 0,84 0,15 0,20 0,91 0,03 0,12 0,15 0,15 
 
 
 
 
 
 
 
 OmcB CT values 
 L2 E US151 
 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 
run1 34,94 
Undeter
mined 30,09 30,53 40,01 37,27 36,27 27,34 30,77 38,76 39,33 40,14 26,82 35,82 29,37 
run1 37,82 
Undeter
mined 30,15 30,53 40,42 36,93 36,80 27,40 30,86 38,30 40,28 38,82 27,14 35,63 37,44 
run1 36,97 
Undeter
mined 30,23 30,30 41,27 36,61 36,42 27,69 30,70 38,46 41,82 39,56 26,93 35,38 43,30 
run2 39,15 
Undeter
mined 29,94 29,94 30,03 37,15 38,92 24,79 29,62 37,39 34,23 35,93 25,66 25,50 27,03 
run2 39,54 
Undeter
mined 29,86 29,96 30,86 37,12 38,92 24,95 29,26 36,45 34,13 35,76 25,72 25,75 27,18 
86 
  
run2 39,45 
Undeter
mined 29,84 29,79 
Undete
rmined 38,82 38,41 25,09 29,41 39,45 34,25 35,93 25,82 25,86 26,92 
run3 35,57 42,05 29,79 24,77 40,02 33,96 34,50 31,69 27,35 34,70 
Undeter
mined 35,11 26,14 26,62 26,87 
run3 35,06 42,07 29,73 24,32 39,96 34,14 33,94 30,98 26,82 34,54 37,98 35,26 26,33 26,55 27,02 
run3 35,38 41,94 28,93 24,58 39,04 35,57 33,75 31,83 27,58 33,66 37,77 35,95 25,72 29,77 26,94 
 
 
 OmcB standard deviation 
 L2 E US151 
 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 
run1 1,48   0,07 0,14 0,79 0,33 0,27 0,19 0,08 0,23 1,26 0,66 0,16 0,22 6,99 
run2 0,21   0,05 0,09 0,59 0,97 0,30 0,15 0,18 1,54 0,06 0,10 0,08 0,18 0,13 
run3   0,09 0,48 0,23 0,49 0,88 0,39 0,46 0,39 0,56 0,15 0,45 0,31 0,04 0,23 
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2. HaCaT 33oC CT and standard deviation values 
 16SrRNA CT values  
 L2     E US151 
 2h 12h 24h 36h 48h 60h 72h 2h 12h 24h 36h 48h 60h 72h 2h 12h 24h 36h 48h 60h 72h 
run
1 
32,
55 
32,
60 
40,
55 
39,
95 
43,
28 
37,
88 
32,
69 
40,
27 
41,
67 
39,
71 
41,
92 
42,
48 
42,
00 
40,
42 
36,
89 
38,
78 
40,
57 
40,
34 
42,
78 
39,
89 
37,
89 
run
1 
32,
43 
32,
30 
41,
94 
39,
76 
42,
07 
37,
39 
32,
87 
41,
10 
42,
46 
40,
59 
41,
51 
41,
59 
42,
07 
40,
57 
36,
34 
38,
56 
41,
03 
40,
46 
43,
89 
39,
89 
38,
46 
run
1 
32,
31 
31,
80 
41,
06 
39,
98 
43,
97 
37,
22 
33,
00 
41,
79 
41,
17 
40,
48 
42,
97 
43,
35 
41,
58 
40,
46 
35,
68 
38,
35 
40,
22 
40,
35 
42,
89 
39,
12 
38,
34 
run
2 
33,
55 
33,
46 
39,
09 
39,
46 
41,
38 
35,
68 
33,
89 
40,
22 
40,
37 
39,
33 
40,
23 
42,
78 
41,
56 
40,
23 
35,
45 
35,
68 
41,
77 
41,
23 
42,
90 
40,
69 
39,
66 
run
2 
32,
79 
33,
46 
39,
78 
38,
46 
41,
27 
35,
24 
33,
90 
40,
48 
40,
46 
39,
27 
40,
46 
42,
46 
41,
25 
41,
46 
34,
91 
36,
35 
41,
78 
40,
56 
41,
67 
39,
57 
39,
10 
run
2 
33,
21 
32,
56 
39,
21 
38,
88 
41,
26 
35,
56 
33,
89 
40,
34 
41,
01 
38,
26 
41,
09 
41,
55 
41,
89 
41,
23 
35,
46 
35,
76 
40,
46 
41,
98 
42,
01 
40,
57 
38,
99 
run
3 
33,
80 
30,
03 
29,
81 
28,
01 
29,
00 
42,
12 
20,
11 
31,
54 
31,
03 
35,
02 
28,
10 
33,
61 
32,
60 
32,
03 
33,
73 
34,
28 
32,
57 
34,
29 
35,
63 
30,
36 
31,
01 
run
3 
32,
34 
29,
81 
29,
64 
28,
04 
28,
83 
41,
00 
19,
90 
31,
39 
31,
23 
34,
88 
28,
68 
33,
39 
32,
53 
31,
97 
33,
27 
34,
45 
32,
16 
34,
25 
35,
26 
30,
26 
31,
17 
run
3 
34,
04 
29,
79 
30,
14 
28,
56 
28,
91 
41,
89 
22,
69 
31,
11 
31,
33 
35,
27 
28,
14 
33,
67 
32,
60 
31,
95 
33,
14 
34,
35 
32,
20 
34,
29 
35,
28 
30,
46 
31,
35 
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 16SrRNA standard deviation 
 L2 E US151 
 2h 12h 24h 36h 48h 60h  72h 2h 12h 24h 36h 48h 60h 72h 2h 12h 24h 36h 48h 60h 72h 
run
1 
0,3
4 
0,0
9 
0,4
5 
0,4
7 
0,3
4 
0,8
1 
0,7
5 
0,0
7 
0,2
3 
0,1
7 
0,4
5 
0,1
1 
0,0
6 
0,0
7 
0,6
5 
0,5
6 
0,0
2 
0,0
1 
0,3
3 
0,0
2 
0,0
6 
run
2 
0,5
6 
0,1
2 
0,2
6 
0,3
3 
0,0
8 
0,5
3 
0,9
4 
0,0
8 
0,4
3 
0,2
3 
0,7
7 
0,2
3 
0,0
5 
0,0
9 
0,4
5 
0,2
2 
0,0
5 
0,0
4 
0,5
6 
0,0
9 
0,0
4 
run
3 
0,9
2 
0,1
3 
0,2
5 
0,3
1 
0,0
9 
0,7
9 
1,5
5 
0,2
2 
0,1
5 
0,2
0 
0,3
2 
0,1
5 
0,0
4 
0,0
4 
0,2
1 
0,1
3 
0,5
3 
0,3
4 
0,9
8 
0,0
7 
0,0
2 
 
 
 groEL -1 CT values 
 L2     E US151 
 2h 12h 24h 36h 48h 60h 72h 2h 12h 24h 36h 48h 60h 72h 2h 12h 24h 36h 48h 60h 72h 
run
1 
37,
95 
36,
88 
41,
99 
40,
92 
41,
58 
39,
31 
39,
85 
39,
57 
41,
90 
39,2
5 
39,
74 
40,
12 
39,2
9 
38,
22 
40,
45 
41,
89 
41,
36 
39,
46 
37,
88 
35,
24 
34,
97 
run
1 
37,
61 
36,
95 
42,
36 
39,
85 
41,
29 
41,
99 
38,
94 
38,
90 
39,
50 
38,5
6 
40,
69 
40,
89 
39,3
5 
40,
24 
40,
81 
41,
24 
40,
78 
38,
24 
37,
10 
35,
09 
35,
06 
run
1 
37,
98 
36,
68 
40,
24 
40,
56 
41,
82 
40,
92 
39,5
1 
39,
28 
40,
54 
39,5
5 
40,
66 
41,
93 
40,4
2 
39,
58 
41,5
7 
41,
41 
39,
92 
39,
46 
38,
18 
35,
77 
35,
26 
run
2 
35,
67 
37,
22 
41,
25 
41,
01 
40,
57 
39,
45 
40,
35 
40,
35 
40,
57 
40,
68 
40,
57 
40,
35 
40,
86 
39,
46 
38,
35 
40,
46 
39,
67 
39,
46 
39,
55 
34,
78 
35,
56 
run
2 
35,
99 
36,
78 
41,
67 
40,
99 
41,
35 
39,
01 
40,
46 
40,
36 
40,
32 
40,
33 
40,
35 
40,
23 
39,
65 
40,
22 
38,
30 
40,
56 
39,
46 
38,
34 
39,
35 
34,
68 
35,
78 
89 
  
run
2 
35,
29 
37,
01 
41,
45 
40,
56 
41,
88 
39,
67 
39,
23 
40,
57 
40,
66 
39,
20 
40,
46 
41,
35 
39,
44 
40,
36 
38,
46 
40,
33 
40,
46 
38,
56 
39,
46 
35,
18 
35,
68 
run
3 
35,
76 
31,
93 
32,
06 
30,
41 
30,
43 
41,
35 
32,
08 
29,
53 
31,
84 
29,
68 
29,
60 
30,
83 
34,
49 
33,
30 
31,
36 
35,
35 
29,
75 
33,
63 
34,
18 
34,
89 
33,
78 
run
3 
35,
62 
31,
69 
31,
97 
30,
27 
30,
41 
41,
33 
32,
15 
29,
38 
31,
52 
29,
77 
29,
64 
30,
94 
34,
67 
33,
59 
31,
67 
35,
13 
29,
57 
33,
98 
34,
56 
34,
02 
33,
89 
run
3 
35,
36 
31,
55 
32,
20 
30,
37 
30,
39 
41,
23 
32,
21 
29,
46 
31,
64 
29,
80 
29,
56 
30,
86 
34,
50 
33,
58 
31,
22 
35,
74 
29,
47 
33,
75 
34,
19 
34,
85 
33,
68 
 
 groEL-1 standard deviation 
 L2 E US151 
 2h 12h 24h 36h 48h 60h 72h 2h 12h 24h 36h 48h 60h 72h 2h 12h 24h 36h 48h 60h 72h 
run
1 
0,2
3 
0,2
2 
0,0
8 
0,5
6 
0,2
0 
0,3
9 
0,2
8 
0,2
5 
0,2
0 
0,2
1 
0,5
4 
0,2
1 
0,3
3 
0,0
3 
0,3
7 
0,2
5 
0,2
6 
0,2
5 
0,2
2 
0,2
7 
0,3
0 
run
2 
0,2
7 
0,3
8 
0,1
7 
0,3
3 
0,2
2 
0,2
8 
0,3
3 
0,3
8 
0,1
0 
0,2
5 
0,3
5 
0,2
3 
0,3
2 
0,2
5 
0,2
6 
0,3
5 
0,2
9 
0,2
4 
0,1
2 
0,2
5 
0,2
9 
run
3 
0,2
0 
0,1
9 
0,1
2 
0,0
7 
0,0
2 
0,0
2 
0,0
7 
0,0
8 
0,1
6 
0,0
6 
0,0
4 
0,0
6 
0,1
0 
0,1
6 
0,2
5 
0,0
3 
0,0
1 
0,2
3 
0,1
2 
0,2
7 
0,1
1 
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 IncB CT values 
 L2     E US151 
 2h 12h 24h 36h 48h 60h 72h 
2
h 12h 24h 36h 48h 60h 72h 2h 12h 24h 36h 48h 60h 72h 
run
1 
39,3
9 
40,6
7 
43,9
5 
42,8
5 
41,2
6 
43,4
5 
39,7
5   
34,7
3 
36,0
7 
39,5
3 
39,7
3 
40,5
0 
39,0
1 
34,3
5   
40,5
6 
42,4
5 
39,5
4 
40,3
3   
run
1 
38,9
8 
41,1
5 
44,4
9 
42,8
4 
43,7
5 
43,6
2 
39,2
0   
34,5
3 
35,7
6 
39,4
7 
40,3
1 
40,4
3 
39,4
3 
34,1
3 
37,3
4 
40,3
6 
42,3
5 
40,6
5 
40,1
2 
37,2
3 
run
1 
40,5
8 
40,9
3   
43,3
1 
42,3
4   
38,1
8   
34,5
3 
34,7
6 
38,6
3 
39,2
9 
39,7
8 
38,8
6 
34,4
6 
37,5
6 
40,6
0 
41,9
7 
40,1
5 
40,3
5 
37,1
3 
run
2 
40,2
3   
42,5
6 
43,2
3 
41,2
3 
44,2
3    
33,4
5 
37,3
5 
39,6
7 
40,5
6 
40,1
3 
38,3
5   
38,2
3 
41,3
5 
40,4
5 
39,4
6 
39,5
7 
38,5
6 
run
2 
40,3
4 
40,2
3 
42,1
2 
43,5
6 
41,3
5 
43,6
7 
38,3
5   
34,9
8 
37,5
6 
39,1
4 
40,1
3 
40,4
6 
38,2
3 
35,4
6 
38,4
5 
41,4
5 
40,4
4 
39,9
1 
39,5
6 
38,6
5 
run
2 
40,2
3 
39,2
3 
43,2
5 
43,8
9 
41,4
5 
43,8
7 
39,4
2   
34,9
8 
37,3
0 
39,2
5 
40,2
3 
40,4
3 
38,1
2 
35,7
9 
37,9
8 
40,5
6   
40,2
3 
40,1
0 
39,4
6 
run
3 
37,6
7 
33,3
2 
34,2
1 
31,1
6 
31,9
2   
23,9
2   
33,3
4 
31,1
1 
30,7
3 
31,9
3 
25,7
0 
24,5
7 
33,4
6 
29,2
3 
31,3
4 
34,9
7 
30,2
6 
29,4
5 
34,5
5 
run
3 
37,1
3 
33,9
3 
34,5
0 
32,1
0 
32,2
5 
39,4
2 
24,1
4   
33,2
1 
30,9
5 
30,8
6 
31,9
6 
25,7
9 
24,6
4 
33,0
9 
29,0
9 
31,3
6 
34,2
9 
30,2
4 
29,4
6 
34,2
5 
run
3 
37,8
5 
34,1
0 
34,1
0 
32,0
1 
32,2
5 
40,8
7 
23,9
3   
33,3
9 
30,9
7 
30,6
0 
31,9
9 
25,8
0 
24,5
2 
33,1
1 
30,0
1 
31,3
4 
34,6
8 
31,0
0 
29,4
4 
34,8
9 
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 incB standard deviation 
 L2 E US151 
 2h 12h 24h 36h 48h 60h 72h 
2
h 12h 24h 36h 48h 60h 72h 2h 12h 24h 36h 48h 60h 72h 
run
1 
0,2
8 
0,3
3 
0,4
3 
0,2
5 
0,3
6 
1,1
1 
0,8
1   
0,2
6 
0,2
0 
0,3
7 
1,1
3 
0,0
2 
0,5
6 
0,1
3 
0,4
6 
0,3
8 
0,2
8 
0,1
1 
0,8
9 
0,4
5 
run
2 
0,0
3 
0,3
8 
0,0
6 
0,0
2 
0,3
6 
1,0
3 
0,0
3   
0,3
9 
0,0
4 
0,0
1 
0,0
9 
0,3
1 
0,0
3 
0,0
4 
0,0
9 
0,2
6 
0,0
7 
0,1
0 
0,0
7 
0,0
4 
run
3 
0,3
8 
0,4
1 
0,2
1 
0,5
2 
0,1
9 
1,0
2 
0,1
3   
0,0
9 
0,0
9 
0,1
3 
0,0
3 
0,0
6 
0,0
6 
0,2
5 
0,4
5 
0,2
9 
0,1
8 
0,0
5 
0,0
3 
0,0
2 
 
 
 
 
 
                     
 Pyk-F CT values 
 L2     E US151 
 2h 12h 24h 36h 48h 60h 72h 
2
h 12h 24h 36h 48h 60h 72h 
2
h 
12
h 24h 36h 48h 60h 72h 
run
1 
37,7
9 
36,8
1 
39,2
5 
40,4
3 
39,8
0 
40,6
5 
39,1
6   
40,2
0 
40,7
8 
39,5
0 
41,6
9 
39,0
5 
39,9
4     
38,4
5 
40,3
5 
39,5
3 
36,1
9 
35,6
7 
run
1 
37,9
6 
36,6
8 
39,2
5 
40,7
1 
40,5
9 
39,9
3 
38,2
1   
40,1
3 
40,8
2 
41,8
1 
40,1
1 
40,1
3 
39,6
3     
37,2
2 
40,4
4 
40,2
3 
36,4
6 
35,5
2 
run
1 
37,5
9 
36,7
3 
40,7
4 
41,9
3 
40,1
0 
40,4
2 
38,8
4   
40,6
9 
40,8
4 
41,8
1 
40,5
0 
39,9
1 
40,6
5     
37,2
3 
40,2
4 
40,1
2 
35,4
6 
36,4
5 
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run
2 
38,1
2 
35,8
7   
40,3
4 
39,2
4 
40,4
3 
39,8
7   
42,6
7 
40,3
4 
39,5
6   
39,5
6 
38,3
4     
36,5
6 
41,3
5 
41,0
1 
36,5
6 
37,5
5 
run
2 
38,2
6 
36,4
5 
40,3
6 
40,2
3 
39,4
6 
39,9
8     
41,3
4 
40,2
5 
39,3
4 
40,2
0 
39,2
4 
39,2
3     
37,4
5 
41,2
3 
40,2
4 
35,5
5 
37,2
3 
run
2 
37,5
6 
35,2
0 
40,2
3 
40,1
2 
40,3
5 
40,2
4 
39,4
3   
41,8
9 
40,3
3 
39,0
2 
40,2
6 
39,0
3       
37,2
3 
40,9
8 
39,3
5 
35,8
9 
37,2
3 
run
3 
35,6
8 
31,4
8 
32,0
8 
30,3
6 
30,3
9 
39,3
1 
38,3
2   
31,7
5 
29,2
4 
29,3
7 
30,4
5 
24,3
5 
23,1
6     
34,8
2 
32,2
6 
33,7
5 
34,2
8 
33,2
6 
run
3 
35,9
4 
31,9
6 
32,1
1 
30,5
7 
30,5
1 
40,3
2 
38,4
5   
31,6
8 
29,5
5 
29,6
0 
30,5
6 
24,3
0 
23,2
2     
34,5
6 
32,5
6 
33,7
3 
34,3
6 
33,4
6 
run
3 
35,7
1 
33,9
0 
32,3
4 
30,2
3 
30,3
1 
39,4
6     
31,4
0 
29,6
2 
29,3
8 
30,4
4 
24,2
5 
23,1
9     
34,3
5 
32,5
7 
33,2
7 
34,7
8 
33,2
4 
 
 
 Pyk-F standard deviation 
 L2 E US151 
 2h 12h 24h 36h 48h 60h 72h 2h 12h 24h 36h 48h 60h 72h 2h 12h 24h 36h 48h 60h 72h 
run1 0,21 0,40 0,24 0,21 0,04 0,21 0,23   0,34 0,03 0,34 0,02 0,05 0,52     0,06 0,56 0,38 0,46 0,02 
run2 0,35 0,27 0,27 0,38 0,56 0,36 0,25   0,19 0,06 0,56 0,03 0,35 0,25     0,21 0,27 0,05 0,35 0,05 
run3 0,14 0,28 0,14 0,17 0,06 0,00 0,22   0,18 0,20 0,13 0,07 0,05 0,03     0,13 0,02 0,05 0,15 0,03 
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 Tal CT values 
 L2     E US151 
 2h 12h 24h 36h 48h 60h 72h 
2
h 
12
h 
24
h 36h 48h 60h 72h 2h 12h 24h 36h 48h 60h 72h 
run
1 
38,4
9 
38,0
5 
41,3
0 
40,6
5 
39,5
8 
41,0
1 
38,9
4       
39,6
5 
39,9
5 
41,3
9 
40,7
4 
40,2
4   
41,2
7 
40,6
8   
40,6
7 
37,8
6 
run
1 
38,2
5 
37,9
6 
40,3
7   
39,9
6 
40,2
8 
40,3
4       
39,4
8 
38,7
0 
41,2
1 
41,2
5 
39,7
5 
39,4
5   
40,9
7 
39,5
8 
41,8
9 
37,8
7 
run
1 
38,0
1 
38,8
2 
41,0
4 
40,3
8 
42,4
5   
40,0
0       
39,0
0 
39,3
7 
40,8
0 
39,9
2 
39,7
5 
39,7
4 
40,5
6 
41,0
8 
39,9
7 
40,9
3 
37,5
5 
run
2 
36,5
6 
39,3
5 
40,4
5 
40,2
7 
39,3
5 
40,9
0 
40,6
8       
38,2
2 
39,7
5 
41,3
5 
42,3
5 
39,5
7 
38,4
5 
40,9
4 
40,7
2 
40,7
6 
41,4
9 
35,8
4 
run
2 
36,9
8 
39,2
8 
41,5
6 
41,9
0 
38,9
1 
40,2
3 
40,1
3       
38,9
1 
39,1
0 
41,1
0 
40,4
4 
39,6
5 
39,9
1 
39,8
5 
39,5
8 
40,2
0 
40,3
4 
35,7
2 
run
2 
37,8
9 
40,0
7 
41,6
5 
41,6
7 
39,3
5 
40,4
0 
40,7
8       
38,3
6 
39,2
3 
41,5
6 
40,1
3   
38,3
5 
39,8
4 
39,4
7 
39,5
6 
40,1
3 
35,8
1 
run
3 
34,2
3 
33,3
6 
34,2
5 
29,4
6 
31,6
5 
35,0
0 
32,4
6       
34,8
3 
32,8
8 
35,0
1 
33,7
4 
31,7
6 
29,9
2 
30,0
7 
30,4
7 
28,3
0 
23,8
7 
23,6
7 
run
3 
35,0
9 
33,3
4 
34,6
8 
29,3
4 
31,8
9 
35,1
1 
32,1
6       
34,8
9 
32,4
6 
34,8
4 
33,3
6 
31,5
9 
29,6
2 
30,8
5 
30,4
7 
28,2
7 
23,9
0 
23,5
7 
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run
3 
35,0
1 
33,4
7 
34,7
8 
29,5
5 
31,3
4 
35,0
9 
32,7
8       
34,5
6 
32,9
9 
34,6
3 
33,4
9 
31,5
9 
29,5
4 
30,1
6 
30,4
6 
28,3
9 
23,9
1 
23,5
0 
 
 
 
 Tal standard deviation 
 L2 E US151 
 2h 12h 24h 36h 48h 60h 72h 2h 12h 24h 36h 48h 60h 72h 2h 12h 24h 36h 48h 60h 72h 
run1 0,34 0,52 0,52 0,73 0,65 1,22 0,74       0,02 0,30 0,67 0,06 0,67 0,38 0,35 0,08 0,07 0,21 0,45 
run2 0,01 0,18 0,28 0,05 0,01 0,09 0,04       0,35 0,04 0,09 0,31 0,09 0,04 0,21 0,16 0,39 0,09 0,08 
run3 0,04 0,15 0,25 0,04 0,03 0,07 0,02       0,07 0,03 0,12 0,45 0,49 0,20 0,43 0,10 0,06 0,02 0,08 
 
 
 hctA CT values 
 L2     E US151 
 2h 12h 24h 36h 48h 60h 72h 
2
h 12h 24h 36h 48h 60h 72h 2h 
12
h 24h 36h 48h 60h 72h 
run
1 
42,1
7 
40,3
3 
42,4
4 
45,9
4 
42,9
5 
43,9
3 
43,3
4   
45,0
5 
42,9
4 
44,6
0 
44,5
4  
37,6
8 
40,2
5   
42,5
5 
41,9
0 
42,1
8 
38,1
5 
38,5
6 
run
1 
42,2
2 
39,5
9   
44,0
0 
43,9
5 
44,2
6 
41,2
0   
45,2
2 
44,3
1 
44,5
7 
46,7
9 42,90 
38,0
1 
40,2
5   
42,9
1 
41,2
4 
41,6
9 
39,2
1 
38,2
4 
run
1 
41,4
3 
40,0
2 
43,9
0 
42,4
8 
44,0
2 
41,9
7 
42,4
3   
44,5
7 
45,3
2 
43,9
8 
45,8
5 42,40 
37,8
8 
41,6
7   
41,3
3 
41,2
4 
42,4
5 
39,4
6 
38,5
6 
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run
2 
41,2
3 
40,2
3 
41,2
3   
43,0
9 
43,2
3 
40,3
5   
45,5
4 
45,3
5 
43,6
3 
45,6
7 41,23 
38,2
3     
42,7
2 
43,9
7 
43,1
9 
39,0
9 
38,7
7 
run
2 
41,0
2 
40,2
3 
42,8
7 
40,2
3 
43,9
8 
41,3
4 
40,2
3   
43,5
4 
45,2
3 
44,3
4 
45,3
3 42,67 
38,2
3 
42,7
8   
41,0
9 
41,3
6   
38,6
8 
39,2
5 
run
2 
41,4
5 
40,4
3 
42,7
8 
40,4
4 
42,3
4 
40,3
4 
40,3
3   
43,6
6 
44,7
8 
44,3
4   42,76 
38,0
1 
42,8
8   
41,4
5 
43,0
1 
43,9
5 
39,2
7 
39,5
9 
run
3 
34,2
3 
29,3
5 
33,0
9 
28,4
5 
30,5
6 
30,2
3 
33,6
5   
34,6
5 
35,0
0 
35,0
9 
35,6
7 33,75 
31,9
4 
34,4
8   
32,2
2 
32,8
7 
30,7
7 
34,9
8 
34,9
6 
run
3 
34,5
5 
29,2
5 
32,9
6 
28,5
6 
30,2
4 
31,4
5 
33,8
4   
35,0
0 
34,9
8 
35,6
5 
35,0
9 33,98 
31,2
5 
33,1
8   
32,2
0 
32,9
2 
30,8
7 
35,0
2 
35,0
0 
run
3 
34,6
7 
29,4
6 
33,4
5 
28,9
8 
30,4
5 
30,8
7 
33,5
6   
34,6
4 
34,9
1 
35,1
6 
36,0
0 33,76 
31,5
5 
34,5
6   
32,7
1 
32,8
9 
30,7
5 
34,9
5 
35,1
2 
 
 hctA standard deviation 
 L2 E US151 
 2h 12h 24h 36h 48h 60h 72h 
2
h 12h 24h 36h 48h 60h 72h 2h 
12
h 24h 36h 48h 60h 72h 
run
1 
0,4
6 
0,5
4 
0,0
5 
0,2
3 
0,1
3 
0,2
9 
0,0
8   
0,1
1 
0,2
9 
0,2
0 
0,3
1 
0,0
8 
0,4
0 
0,0
4  
0,3
8 
0,4
6 
0,0
8 
0,0
9 
0,6
5 
run
2 
0,3
8 
0,0
7 
0,3
5 
0,1
2 
0,5
6 
0,2
7 
0,3
7   
0,0
2 
0,3
5 
0,2
6 
0,3
4 
0,0
3 
0,0
6 
0,2
3  
0,0
6 
0,3
8 
0,2
0 
0,1
7 
0,0
4 
run
3 
0,2
3 
0,0
2 
0,0
3 
0,1
5 
0,3
4 
0,2
2 
0,1
9   
0,0
4 
0,2
5 
0,3
9 
0,2
5 
0,0
6 
0,0
4 
0,1
2  
0,2
9 
0,0
3 
0,0
6 
0,0
4 
0,0
8 
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 OmcB CT values  
 L2     E US151 
 2h 12h 24h 36h 48h 60h 72h 
2
h 
12
h 24h 36h 48h 60h 72h 2h 12h 24h 36h 48h 60h 72h 
run
1 
39,9
4 
39,2
2 
41,1
3 
43,1
5 
39,9
3 
40,7
7 
39,3
0     
42,0
2 
41,9
8 
43,9
5 
40,2
7 
42,7
6 
38,2
3  
40,5
6 
43,5
6 
40,4
6 
39,4
6 
38,9
6 
run
1 
39,5
2 
39,2
5 
40,3
0 
40,4
5 
38,9
9 
41,3
2 
42,4
2     
40,8
2 
41,9
8 
42,1
7 
41,6
4 
42,7
6 
38,4
6 39,35 
40,7
8 
43,9
8 
40,8
6 
39,0
8 
38,9
4 
run
1 
40,5
6 
40,7
0   
42,3
7 
39,5
7 
40,4
6 
39,4
0     
41,9
3 
42,1
7 
39,9
5 
40,0
1 
42,0
3 
39,7
8 39,10 
40,1
3 
44,7
7 
40,7
6 
39,8
3 
38,8
7 
run
2 
39,2
3 
40,5
5 
40,7
4 
42,6
6 
39,9
9 
40,3
5 
42,4
5     
40,4
0 
41,2
3 
43,6
6 
41,8
9 
40,7
6 
39,0
0 40,44 
43,5
5 
43,9
0 
40,2
8 
38,5
8 
39,6
6 
run
2 
39,7
9 
40,2
9 
41,9
8 
41,9
1 
40,3
5 
40,0
9 
42,3
5     
40,5
6 
41,0
1 
43,9
0 
41,5
7 
41,4
4 
39,2
6 39,95 
42,9
9   
40,3
4 
38,8
9 
39,7
8 
run
2 
38,9
9 
40,7
1 
41,3
7 
41,5
6 
38,3
6 
41,6
5 
41,8
7     
40,2
7 
40,2
3 
43,6
5 
41,0
6 
40,7
7 
39,6
7 39,65 
42,1
0 
42,8
9 
40,6
8 
39,7
6 
39,8
9 
run
3 
31,3
5 
34,4
5 
30,5
5 
33,6
9 
28,4
6 
32,1
6 
34,4
5     
33,3
3 
35,8
9 
34,2
8 
31,6
4 
33,5
6 
32,9
4 30,59 
30,8
6 
31,1
6 
38,9
7 
34,6
6 
34,2
9 
run
3 
31,6
6 
34,7
8 
30,2
4 
33,7
8 
28,4
6 
32,9
8 
34,8
9     
33,7
8 
35,5
6 
34,3
5 
31,1
4 
33,9
4 
32,7
7 30,47 
30,8
3 
31,2
2 
38,9
8 
34,4
9 
24,0
9 
run
3 
31,8
4 
34,7
9 
30,2
5 
33,1
2 
28,3
6 
32,5
7 
34,4
4     
33,9
0 
35,2
8 
34,7
9 
31,4
6 
33,6
7 
32,6
1 30,44 
30,9
2 
31,2
0 
38,9
9 
34,6
1 
34,3
0 
 
 
 omcB standard deviation 
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 L2 E US151 
 2h 12h 24h 36h 48h 60h 72h 
2
h 
12
h 24h 36h 48h 60h 72h 2h 12h 24h 36h 48h 60h 72h 
run
1 
0,5
7 
0,2
8 
0,2
1 
0,5
5 
0,6
3 
0,1
3 
0,2
8     
0,6
7 
0,1
1 
0,0
1 
0,2
7 
0,3
8 
0,2
4 
0,0
6 
0,2
6 
0,3
9 
0,4
8 
0,6
7 
0,1
1 
run
2 
0,0
7 
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3. HeLa 37oC CT and standard deviation values 
 16SrRNA CT values  
 L2 E US151 
 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 
run1 32,12 30,95 30,83 30,89 34,00 36,25 35,09 27,53 37,96 32,49 32,85 32,23 31,64 35,81 32,76 
run1 31,97 31,01 30,26 31,13 33,22 36,84 35,81 27,24 38,30 32,96 31,98 29,88 31,74 35,80 33,28 
run1 30,96 30,30 30,27 31,18 34,10 37,56 34,71 28,15 37,87 32,23 32,97 31,49 31,77 35,69 32,72 
run2 33,51 33,41 33,29 33,77 33,88 36,23 35,35 27,21 37,77 32,43 32,77 31,43 31,33 35,23 33,22 
run2 34,10 33,07 33,20 34,24 33,92 36,23 35,21 27,98 37,34 32,44 32,65 31,65 31,41 35,09 32,98 
run2 33,31 32,94 33,29 33,71 33,80 36,87 35,87 27,34 37,65 32,76 32,55 31,44 31,21 35,44 33,11 
run3 32,16 32,19 32,40 31,98 32,51 37,01 34,21 28,11 38,11 33,11 33,54 32,33 31,32 35,97 32,87 
run3 32,11 32,41 32,77 31,99 32,42 37,11 34,54 28,32 38,23 32,54 33,13 32,16 31,65 35,56 33,15 
98 
  
run3 32,02 32,48 31,68 31,91 32,68 37,09 34,87 28,19 38,74 32,66 33,23 33,97 31,43 35,33 33,71 
 
 16SrRNA standard deviation 
 L2 E US151 
 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 
run1 0,63 0,39 0,33 0,15 0,67 0,65 0,56 0,47 0,49 0,79 0,54 1,20 0,06 0,07 0,31 
run2 0,07 0,15 0,55 0,04 0,13 0,03 0,02 0,03 0,32 0,34 0,07 0,23 0,04 0,05 0,05 
run3 0,03 0,01 0,43 0,04 0,05 0,12 0,32 0,12 0,34 0,33 0,05 0,04 0,05 0,06 0,34 
 
 
 groel-1 CT values  
 L2 E US151 
 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 
run1 39,23 40,89 40,12 31,74 37,911 33,25 35,26 37,11 31,22 34,24 35,47 35,27 38,03 37,12 40,99 
run1 39,52 39,26 40,67 31,90 36,93 33,76 35,56 37,23 32,01 34,64 35,61 35,06 37,55 36,99 40,12 
run1 39,36 39,42 41,80 31,65 37,98 33,22 35,22 37,33 31,34 34,66 35,06 34,96 37,10 36,95 39,92 
run2 39,25 40,11 40,23 31,65 37,33 34,13 35,45 37,92 31,98 34,12 35,02 34,99 37,98 36,11 40,55 
run2 39,22 40,46 40,55 31,33 37,82 34,11 35,77 37,12 31,34 34,76 35,76 34,78 37,66 36,85 40,34 
run2 39,67 40,23 40,15 31,68 37,23 34,02 34,99 37,54 32,81 34,36 35,22 34,22 37,23 36,33 40,66 
run3 39,44 39,23 40,45 31,83 37,91 33,23 35,22 37,55 31,45 34,12 35,01 35,76 37,33 36,36 40,23 
run3 39,23 39,12 40,12 31,22 37,44 33,76 35,01 35,62 31,55 34,65 35,9 35,11 37,48 36,12 40,88 
run3 39,88 39,32 40,11 31,09 37,76 33,21 35,22 35,12 31,22 34,22 35,56 35,77 37,58 36,92 40,24 
99 
  
 
 groEL-1 standard deviation 
 L2 E US151 
 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 
run1 0,15 0,90 0,80 0,13 0,04 0,08 0,04 0,07 0,09 0,12 0,29 0,16 0,47 0,09 0,76 
run2 0,04 0,01 0,04 0,03 0,23 0,06 0,03 0,07 0,04 0,01 0,04 0,02 0,05 0,06 0,05 
run3 0,03 0,15 0,05 0,07 0,09 0,03 0,01 0,04 0,08 0,05 0,03 0,01 0,03 0,03 0,05 
 
 
 
 Pyk-F CT values 
 L2 E US151 
 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 
run1  41,68 41,74 31,61 36,58  36,95 34,51 45,51 37,08  38,24 40,49 36,71 40,21 
run1  41,79 41,32 31,81 35,74  36,91 34,69 45,00 36,41  37,94 40,21 36,74 40,23 
run1  41,90 40,42 30,92 36,53  36,22 34,87 45,97 37,98  39,42 39,32 36,49 41,18 
run2   41,53 40,56 31,56 35,65   35,98 34,27 44,23 36,25   38,34 40,21 37,23 39,34 
run2   40,98 39,99 30,98 35,33   35,23 35,01 45,22 36,19   38,34 40,22 37,12 39,33 
run2   40,69 41,01 30,65 36,56   35,87 35,56 45,23 36,34   38,64 40,74 37,32 39,65 
run3   41,45 39,98 31,34 36,22   35,21 34,31 44,09 36,98   39,12 39,85 36,54 40,12 
run3   41,09 39,84 31,67 35,23   36,33 34,26 44,65 36,32   39,54 40,13 36,87 40,11 
100 
  
run3   40,97 39,45 31,02 35,61   36,34 34,61 44,32 36,18   38,97 39,34 36,33 40,21 
 
 Pyk-F standard deviation 
 L2 E US151 
 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 
run1  0,13 0,93 0,47 0,11   0,41 0,18 0,23 0,37   0,78 0,83 0,14 0,69 
run2    0,04 0,05 0,07 0,18   0,15 0,03 0,07 0,08   0,13 0,07 0,05 0,06 
run3   0,02 0,07 0,06 0,09   0,13 0,04 0,06 3,00   0,14 0,03 0,02 0,02 
 
 
 
 hctA CT values 
 L2 E US151 
 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 
run1   44,00 34,25 32,86   35,16 45,04 37,54   43,16 36,09 43,00 
run1   44,01 34,23 32,96   34,92 44,91 38,35   42,91 36,13 43,86 
run1   44,11 33,92 32,66   35,50 45,36 37,15   43,07 35,99 43,91 
run2   44,90 35,40 36,73    35,02 45,56 36,96     43,74 35,46 42,35 
run2   44,76 35,53 36,87     35,26 45,62 37,50     44,01 35,10 43,09 
run2   44,49 35,52 37,69     35,56 45,09 37,27     44,46 35,55 43,24 
run3   43,20 33,37 31,86     34,75 44,46 37,09     43,89 36,71 42,12 
101 
  
run3   44,29 33,16 30,97     34,55 44,71 36,44     43,65 36,09 42,88 
run3   45,44 32,97 31,35     35,01 45,34 37,02     44,46 35,68 43,00 
 
 hctA standard deviation  
 L2 E US151 
 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 2h 12h 24h 36h 48h 
run1     0,08 0,04 0,07     0,29 0,23 0,61     1,12 0,20 0,45 
run2     0,11 0,07 0,29     0,07 0,09 0,05     0,12 0,05   
run3      0,09 0,09 0,08     0,04 0,12 0,08     0,14 0,07 0,04 
 
 
 
 
 
  
 
